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ABTRACT OF THE DISSERTATION
AN EVALUATION OF FUNCTIONAL IMPAIRMENT AMONG CHILDREN WITH
ANXIETY DISORDERS
by
Irina Fredericks
Florida International University, 2011
Miami, Florida
Professor Wendy K. Silverman, Major Professor
Despite a considerable progress in developing and testing psychosocial treatments
to reduce youth anxiety disorders, much remains to learn about the relation between
anxiety symptom reduction and change in youth functional impairment. The specific aims
of this dissertation thus were to examine: (1) the relation between different levels of
anxiety and youth functional impairment ratings; (2) incremental validity of the Children
Global Assessment Scale (CGAS); (3) the mediating role of anxiety symptom reduction
on youth functional impairment ratings; (4) the directionality of change between anxiety
symptom reduction and youth functional impairment; (5) the moderating effects of youth
age, sex, and ethnicity on the mediated relation between youth anxiety symptom
reduction and change in functional impairment; and (6) an agreement (or lack thereof)
between youths and their parents in their views of change in youth functional impairment
vis-à-vis anxiety symptom reduction.
The results were analyzed using archival data set acquired from 183 youths and
their mothers. Research questions were tested using SPSS and structural equation
modeling techniques in Mplus.
v

The results supported the efficacy of psychosocial treatments to reduce the
severity of youth anxiety symptoms and its associated functional impairment. Moreover,
the results revealed that at posttreatment, youths who scored either low or medium on
anxiety levels scored significantly lower on impairment, than youths who scored high on
anxiety levels. Incremental validity of the CGAS was also revealed across all assessment
points and informants in my sample. In addition, the results indicated the mediating role
of anxiety symptom reduction with respect to change in youth functional impairment at
posttest, regardless of the youth’s age, sex, and ethnicity. No significant findings were
observed with regard to the bidirectionality and an informant disagreement vis-à-vis the
relation between anxiety symptom reduction and change in functional impairment.
The study’s main contributions and potential implications on theoretical,
empirical, and clinical levels are further discussed. The emphasis is on the need to
enhance existing evidence-based treatments and develop innovative treatment models
that will not only reduce youth’s symptoms (such anxiety) but also evoke genuine and
palpable improvements in lives of youths and their families.
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CHAPTER I.
INTRODUCTION
Anxiety disorders represent the single largest mental health problem in childhood
and adolescence with the prevalence rate as high as 20.2% in community and 44.7% in
clinic samples (Costello, Mustillo, Erkanli, Keeler, & Angold, 2003; Murray, Creswell, &
Cooper, 2009). Anxiety disorders are associated with multiple and significant impairment
in psychosocial functioning, including social relations and academic performance (Essau,
Conradt, & Petermann, 2000; Ezpeleta, Keeler, Erkanli, Costello, & Angold, 2001;
Ialongo, Edelsohn, Werthamer-Larsson, Crockett, & Kellam, 1995; Rapee, Schniering, &
Hudson, 2009). Early-onset anxiety disorders are likely to be chronic if untreated and
tend to predispose children to future psychological disorders, such as depression and
substance abuse (Cole, Peeke, Martin, Truglio, Serocynski, 1998; Kovacs & Devlin,
1998; Zahn-Waxler, Klimes-Dougan, & Slattery, 2000).
In recognition of anxiety disorders’ debilitating effects on important areas of
functioning, a substantial body of research has evolved over the past two decades
evaluating the efficacy of psychosocial treatments for anxiety reduction in children and
adolescents (from here on referred to as youth unless specifying a specific developmental
period). Silverman, Pina, and Viswesvaran (2008) reviewed and classified the status of
evidence-based psychosocial treatments in 32 studies using Chambless et al.’s (1996),
Chambless and Hollon’s (1998), and Nathan and Gorman’s (2002) criteria. A number of
treatments were found to meet criteria for “probably efficacious” and “possibly
efficacious.” All treatments that employed exposure based Cognitive Behavioral
Treatment (CBT) were found to be efficacious whether delivered in individual (ICBT),
1

parent involvement (PCBT), or group (GCBT) formats (Barrett, 1998; Barrett, Dadds, &
Rapee, 1996; Beidel, Turner, & Morris, 2000; Kendall, Hudson, Gosch, FlannerySchroeder, & Suveg, 2008; Marin, 2010; Silverman et al., 1999; Silverman, Kurtines,
Jaccard, & Pina, 2009; Walkup et al., 2008).
Despite the progress made in treatment development and evaluation, much
remains to learn about how successful CBT for anxiety disorders impacts youths’ daily
life functioning. No study has yet to evaluate directly the relation between symptom
reduction and changes in functional impairment among youths with anxiety disorders.
Statements about how, under what condition, with whom, and in what direction anxiety
symptom reduction impacts youth functioning are therefore likely to be based on
assumptions rather than empirical data (Kazdin, 1999). Thus, what the quality of the
relation is between symptom reduction and change in youth functional impairment is, at
this point, essentially an empirically unanswered question.
There is a need for research that moves beyond questions of treatment efficacy to
questions evaluating change in functional impairment among youth with anxiety
disorders vis-à-vis anxiety symptom reduction. Specifically, the following questions have
not been asked in any youth anxiety treatment study and were asked in this dissertation:
(1) What is the relation between different levels (i.e., low, medium, and high) of anxiety
symptom severity and youth functional impairment ratings as measured by both the
Children’s Global Assessment Scale (C-GAS; Shaffer et al., 1983) and the Clinician
Severity Ratings (CSR; Silverman & Albano, 1996)? (2) Do functional impairment
ratings measured by the CGAS predict impairment above and beyond measures of
anxiety severity symptoms, indicating incremental validity of the CGAS? (3) Does the
2

impact of psychosocial treatments aimed at reducing youth phobic and anxiety disorders
in a PCBT (targeting parenting behaviors and the parent-youth relationship) and a GCBT
(targeting youth social skills behaviors and the peer-youth relationship) approach mediate
change significantly in youth functional status? (4) What is the directionality of change in
the proposed mediated relation between anxiety symptoms and youth functional
impairment? (5) Does the proposed mediated relation between anxiety symptoms and
youth functional impairment vary as a function of youth age, sex, and ethnicity? (6) Is
there an agreement (or lack thereof) between youths and their parents in their views of
change in youth impairment vis-à-vis anxiety symptom reduction?
Providing empirically derived answers to these six research questions constituted
the specific objectives of this dissertation. Each of the objectives along with the relevant
background information is elaborated upon in Chapter II of the dissertation. As will
become apparent shortly from the literature review, the present study is the first empirical
investigation in the field of youth anxiety treatment to move beyond efficacy by
evaluating youth functional impairment vis-à-vis anxiety symptom reduction.
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CHAPTER II.
LITERATURE REVIEW
In this chapter, functional impairment is discussed. The focus is first, on its
special aspects, including operational definition and conceptualization, major domains of
functioning, and measures of assessment. This is followed by a brief discussion on the
scarcity of empirical knowledge about the impact of CBT interventions on functional
impairment among youth with anxiety disorders. The emphasis is on whether anxiety
symptom reduction is a significant mediator of positive change in youth functional status.
A summary of the present study’s research questions and hypotheses completes Chapter
II of this dissertation.
Functional Impairment and Its Special Aspects
Operational definition. Functional impairment refers to severe problems in daily
life functioning as a consequence of psychological symptoms or disorders, leading to the
need for mental health services (Diagnostic and Statistical Manual of Mental Disorders,
4th ed. [DSM–IV-TR]; American Psychiatric Association [APA], 2000). In youth
psychological research, the construct of adaptive functioning refers to the relative ability
of the youth to effectively care for one's self, interact with others, and meet demands of
social role performance and role satisfaction in various settings and situations (Üstun &
Chatterji, 1997). High levels of functional impairment predict the likelihood youth will be
referred for treatment, more so than psychiatric symptoms alone (Bird, 1999; Kazdin,
1999). Impairment can interfere substantially with or limit youths’ functioning in terms
of all important life skills (e.g., communication, self-care, social/interpersonal, self-
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direction, academic, leisure, and safety) in family, school, or community settings (APA,
2000; Bird, 1999).
For nearly two decades, the DSM–IV-TR (APA, 2000) taxonomy required the
concept of ‘mental disorder’ to be applied only to individuals who both meet the
symptom criteria for a disorder and experience a significant degree of functional
impairment associated with the symptoms (APA, 2000). The ascertainment of functional
impairment thereby gained relevance, including in clinical research and practice, as well
as epidemiological investigations. Impairment in functioning is a criterion for
determining clinical diagnoses, treatment efficacy, mental health service eligibility, and
psychological disorder prevalence estimates (Bird, 1999; Costello, Egger, Copeland,
Erkanli, & Angold, 2009; Kramer et al., 2004).
Functional impairment is difficult to operationalize and ascertain because it is in
part a subjective epiphenomenon that depends on a number of individual factors, such as
intelligence, competence, personal characteristics, and communication styles (Bird,
1999). Measuring degree of functional impairment can further be influenced by
contextual factors, such as the culture of the environment and society’s goals and
expectations (Angold et al., 2002). This notion is especially relevant to clinicians and
researchers in the USA whose work often involves evaluating individuals from different
ethnic groups and cultural backgrounds. An individual’s functional status may incorrectly
be judged as impaired because of a rater’s or clinician’s unawareness of the individual’s
“cultural frame of inference” (APA, 2000, p. xxxiv) for adaptive functioning.
Operationalizing youths’ functioning is also complicated by the need to consider
developmental factors to evaluate whether the youth’s ability to cope with common life
5

demands and meet the standards of personal independence is at the level appropriate for
his or her age group (Bird, 1999). “Functional impairment” is therefore a multifaceted
and multidimensional concept, the operational definition and ascertainment of which
requires taking into account various individual and contextual factors interacting in
multitude and complex ways (APA, 2000).
Conceptualization. As stated by Kazdin (1999), the concept of functional
impairment is closely linked with but “readily distinguishable” (p. 333) from the concepts
of personal distress, and the symptoms and severity of a given psychological disorder.
Specifically, personal distress represents one’s subjective evaluation of levels of stress,
discomfort, and emotional pain caused by psychological symptoms (Ezpeleta, Reich, &
Granero, 2009). Functional impairment, in contrast, refers to the consequences that
psychological symptoms or disorders have on the youth’s performance in all important
areas of functioning (Üstun & Chatterji, 1997). Although personal distress has often been
used as a proxy for impairment (i.e., symptoms/disorders that cause functional
impairment at home, at school, or with friends also cause high levels of distress), the
concepts of functional impairment and personal distress are not interchangeable and thus
should be evaluated independently (Ezpeleta et al., 2009).
Compared to symptoms that represent the behavioral feature of a given disorder,
and severity that represents the level of seriousness of the disorder, impairment in
adaptive functioning represents the disorder’s impact on the individual and others (Bird,
1999). Although both severe symptoms and functional impairment are core diagnostic
features of all disorders listed in DSM-IV-TR and both are required criteria for diagnoses,
they are not invariably related (Kasdin, 1999).
6

Distinguishing between the concepts of symptoms and impairment is important
because a number of studies have shown there are youths who do not meet DSM-IV-TR
criteria for a specific disorder but who have symptoms associated with functional
impairment and thus are still in need of mental health services (Angold & Costello, 1996;
Costello & Shugart, 1992; Wells, Burnam, Rogers, Hays, & Camp, 1992). For instance,
Angold, Costello, Farmer, Burns, and Erkanli (1999) found that youths with subthreshold
disorders but who had symptomatic impairment were as disturbed as youths with a
diagnosis but without impairment. These findings raise questions about whether the
field’s focus on developing and evaluating disorders specific treatments, although has
moved the field forward, still is limited by its relative inattention to the relation between
symptom reduction and improvement in impairment.
As Kazdin (1999) pointed out, clinical significance in treatment outcome research
has largely been evaluated by symptom reduction. However, treatments may reduce
symptoms to normative levels but not necessarily produce significant changes in
functional impairment. It is therefore important to evaluate whether symptom reduction
mediates improvements in youth functional status. Empirical knowledge about how (e.g.,
significantly or not, negatively or positively), under what condition (e.g., severity level,
point of development), with whom (e.g., girls versus boys), and in what direction (e.g.,
symptom to impairment or vice versa) symptom reduction produces change in youth
functional impairment can help to improve evidence-based treatments’ designs, delivery,
and outcomes. Symptom reduction is important but it may not reflect significant and
palpable changes in youth’s daily functioning (Kazdin, 1999).
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Major domains of functioning. In child and adolescent research, functional
impairment has been evaluated along three major domains (Bird, 1999). The first domain
is interpersonal relationships. Interpersonal relationships concern both the qualitative and
quantitative aspects of youths’ relations with peers, family members, and other adults
with whom youths interact on a regular basis outside the family (e.g., teachers, church
leaders). The second domain is the academic performance. Academic performance
concerns the youth’s ability to perform in school without undue anxiety and at the level
consistent with their potential. The third domain is the capacity to enjoy life. The capacity
to enjoy life concerns the youth’s utilization of leisure time for self-fulfillment through a
wide range of extracurricular activities, interests, or hobbies. Other specific areas that
relate to these three domains and, according to Bird (1999), are necessary to evaluate are
an age-appropriate cognitive level, verbal skills, and a capacity for self-care.
Measures of assessment. A variety of assessment scales have been developed to
assess youth functioning (Hodges & Gust, 1995). A number of scales are domain
specific, evaluating youth functioning in one of the major domains discussed above. For
instance, peer sociometric rating scales (e.g., Teacher Assessment of Social Behavior;
Cassidy & Asher, 1992) evaluate youths’ functioning with respect to interpersonal
relationships. Standardized intelligence and academic achievement tests (e.g., Wechsler
Intelligence Scale for Children – fourth edition; Wechsler, 2004) evaluate youths’
functioning with respect to their potential for academic performance. Other instruments
are multidimensional, assessing youth functioning across the three major domains. For
instance, the Child and Adolescent Functional Assessment Scale (CAFAS; Hodges &
Kim, 2000; Hodges & Wong, 1996) is an interviewer and caregiver rated measure of
8

youths’ functional impairment with regard to their interpersonal relations, academic
performance, and self-fulfillment.
Although these and other domain specific and multidimensional measures are
well-validated measures of impairment (Hodges & Gust, 1995), they have limitations
(Fabiano et al., 2009). The use of domain specific scales requires administration of
multiple measures to obtain comprehensive assessment of youth functional impairment,
limiting their practical utility, for example, in terms of repeated measures. The use of
multidimensional measures of functional impairment in youth, such as the CAFAS, is
limited by the need to administer an interview, as well as the lack of uniformity across
informants (Fabiano et al., 2009).
An alternative way to evaluate youth functioning is by using global measures of
impairment. Given that functional impairment refers to overall functioning, global
impairment ratings are perhaps the most useful scales to assess youth functional status
(Bird, Canino, Rubio-Stipec, & Ribera, 1987). Global measures conceptualize
impairment as one, unified construct of youth’s overall functioning across the major
domains discussed earlier, providing a single score that represents the amount of
impairment that the psychological symptoms or disorders cause the youth. A wide range
of scales has been developed to measure global impairment, including Axis V of DSM–
IV-TR (APA, 2000) and the Columbia Impairment Scale (CIS; Bird et al., 1993). One of
the most widely used global measures of youth impairment is the Children’s Global
Assessment Scale (CGAS; Shaffer et al., 1983).
The CGAS is a clinician rated scale of adaptive functioning derived from the
Global Assessment Scale for adults (Endicott, Spitzer, Fleiss, & Cohen, 1976). The scale
9

is divided into 10 deciles that contain references to behavioral descriptors of clinical
manifestation of symptoms in terms of their impact on youths’ school performance,
relationships to others, interests, and hobbies. Based on these descriptors, raters
synthesize the knowledge about the youth’s psychological and social functioning and
assign a single numerical global score of impairment ranging from 100 (highest level of
functioning) to 1 (lowest level of functioning).
Numerous psychometric studies have been conducted on the CGAS,
demonstrating its utility in discriminating between clinical and nonclinical groups (Bird
et al., 1987; Schorre & Vandvik, 2004; Shaffer et al., 1983; Steinhausen & Metzke,
2001). Because the CGAS was used in this dissertation, further information on its
psychometric properties is provided in the Measures section. Of note is that the CGAS
does not provide specific information on impaired areas of youth functioning.
Nonetheless, its anchor points within the respective rating decile reflect both symptom
severity and interference, adding “a dimension to the definition of disorders that goes
beyond categorical diagnostic ratings or symptom-specific scales” (Bird, 1999, p. 218).
In child and adolescent anxiety treatment research, the Clinician Severity Rating
scale (CSR; Silverman & Albano, 1996) is one of the most widely used global measures
of youth impairment. The CSR is part of the Anxiety Disorders Interview Schedule for
DSM-IV: Child and Parent Versions (ADIS-C/P; Silverman & Albano, 1996). The
ADIS-C/P is a semi-structured interview administered to the youth and parent to assess
the presence of anxiety and other psychological disorders. Based on youth and parent
informants, the CSR assesses the relative interference of the symptoms reported with
respect to youths’ school performance, friendships, family relations, and youths’ personal
10

distress. In addition, the CSR assesses whether youth functioning is at the age-appropriate
level, indicating the scale’s sensitivity to developmental factors.
The CSR scores range from 0 (Not At All) to 8 (Very, Very Much), with the scores
of 4 or higher viewed as definitely interfering and impairing. To derive a combined score
of the CSR, an interviewer considers both the youth’s and parent’s views and adjusts the
interference score to the higher of the two CSRs for each endorsed diagnosis. Because the
CSR was used in this dissertation, further information on its psychometric properties is
provided in the Measures section. Given that a decrease in subjective distress and severity
is a measure of clinical improvement (APA, 2000; Ezpeleta et al., 2009), the CSR is
useful for assessing treatment efficacy.
The evaluation of youth functional impairment, as assessed by both the CGAS
and the combined CSR, is useful. First, it allows for the assessment of youth functional
impairment within a developmentally sensitive framework, which accounts for both the
domains and degree of interference relative to normative youth development. Second, it
provides for an understanding of the degree to which an individual child or adolescent is
dysfunctional or impaired. Third, it allows researchers and clinicians to ascertain whether
a specific psychosocial treatment produces meaningful and significant changes in lives of
youths and their families (Kazdin, 1999). Finally, it allows for the evaluation of
incremental validity of the CGAS in relation to the CSR. Incremental validity refers to
“the degree to which a measure explains or predicts a phenomenon of interest, relative to
other measures” (Haynes & Lench, 2003, p. 456) and depends on the goal of the
assessment, whether it is to improve diagnostic efficacy or evaluate treatment outcome
(Johnston & Murray, 2003). Evaluating incremental validity of the CGAS can help to
11

ascertain its utility in predicting impairment above and beyond measures of anxiety
severity symptoms.
The Evaluation of Functioning in Youth with Anxiety Disorders
The presence of functional impairment is an explicit component of all
psychological disorders listed in DSM-IV-TR, including youth phobic and anxiety
disorders. In fact, the symptoms of an anxiety disorder are only valid indexes if they
cause persistent, pervasive, and significant interference or impairment in social,
academic, or other important areas of functioning (APA, 2000). Research suggests that
the prevalence rate of youth anxiety disorders, especially specific phobia, is the most
affected by including an evaluation of functional impairment to make a diagnosis, more
so than that of all other diagnoses (Costello et al., 2009). Thus, when evaluating anxiety
treatment outcome, it is important to examine its impact on not only the symptoms of a
given anxiety disorder but also level of functional impairment associated with the
symptoms (Kazdin, 1999).
As stated earlier, the past two decades have witnessed a considerable progress in
developing and testing psychosocial treatments to reduce youth anxiety disorders. As a
result, there now exists a large body of research supporting the efficacy of CBT for
treating anxiety disorders in youth (e.g., Silverman et al., 2008). Existing research
evidence supporting the efficacy of CBT to reduce youth anxiety symptoms however
does not necessarily mean that CBT outcome (i.e., symptom reduction) is efficacious to
reduce impairment in youth’s functioning– it may or may not (Kazdin, 1999). It is
important to demonstrate this empirically. The issue of the field’s relative inattention to
change in youth functional status vis-à-vis successful treatment outcomes with respect to
12

how, under what condition, with whom, and in what direction the change occurs thus
comprised the main goal of this dissertation. Its specific aims are elaborated upon in more
detail in the following sections.
Levels of Anxiety Symptoms
Not one study has yet investigated the relation between different levels (i.e., low,
medium, high) of youth anxiety symptoms and functional impairment. Thus, extending
past outcome research by evaluating directly whether low, medium, and high level of
anxiety symptoms differentially relate to youth functional impairment was the first
objective of this dissertation. The evaluation of the linkages between youth levels of
anxiety symptom and functional impairment ratings is important because it can help to
address the issue of metrics arbitrariness in psychological research and practice. As stated
in Blanton and Jaccard (2006), “metric” is a rating a person gives to items on
psychological measures. A metric is arbitrary when it is unknown how a change in scores
translates into the change in the person’s real world experiences. For instance, a child
receives a score of 15 on an anxiety measure at pretreatment and a score of 5 at
posttreatment. The meaning of the anxiety score change is arbitrary because it does not
convey how it translates into the change in the child’s real world experiences. One
strategy to reduce the arbitrariness of metrics is norming approach (Blanton & Jaccard,
2006). This approach involves grouping anxiety symptom severity scores in terms of
magnitude (i.e., low, medium, or high) and linking them to observable and meaningful
changes in the outcome of interest – namely, youths’ functional status across major
domains of functioning discussed earlier. Although not sufficient to generate nonarbitrary

13

metrics, the norming procedure can help to address the issue of metric arbitrariness
(Blanton & Jaccard, 2006).
Evaluating the linkages between different levels of anxiety and functional
impairment can also help to identify individuals whose mental health is a cause for
concern and who are considered to be in need of mental health services. This knowledge
is important because it can (1) help clinical researchers to prioritize interventions, (2)
better understand the phenomenology of disorders in youth, (3) refine diagnostic criteria,
and (3) guide community-based mental health administrators in their decision making
with respect to resource allocation for youths and their families seeking services in real
world clinical settings (Bird, 1999).
Incremental Validity of the CGAS
As discussed earlier, the CGAS and the CSR are the most useful global measures
of youth functional impairment in youth psychological research. Not one study however
has yet evaluated predictive or incremental validity of the functional impairment
measures -- particularly, whether CGAS ratings account for unique and substantial
variance in CSR scores, independent of measures of anxiety symptom severity. Thus,
extending past outcome research by assessing incremental validity of the CGAS to
evaluate its predictive value of impairment above and beyond information already
available (e.g., measures of anxiety symptom reduction) was the second objective of this
dissertation.
Evaluating empirically whether CGAS ratings predict impairment above and
beyond anxiety symptom measures is important. It can help to examine the efficiency of
assessment protocols, justify the use of exiting assessment measures, and hence to
14

ascertain that psychological services are carried out in a way that is maximally beneficial
to clients (APA, 2002; Johnston & Murray, 2003). Addressing incremental validity is
also useful in research involving multiple informants (e.g., clinicians, youths, parents)
because it helps to evaluate the contribution of each informant to the outcome of interest
(Haynes & Lench, 2003). Taken together, evaluation of incremental validity is important
because it can provide a fine-grained assessment of treatment outcome that pays due
attention to improvements in functional impairment following treatment, associated with
but assessed independently from the symptoms.
Functional Impairment Mediation
No study in the field of treatment outcome has yet evaluated the mediating role of
the impact of anxiety symptom reduction on youth functional impairment. Extending
existing outcome research by providing empirical knowledge about whether anxiety
symptom reduction mediates significantly change in youth functional impairment was the
third objective of the present study.
There are several reasons why empirical evaluation of youth functional
impairment mediation by positive treatment outcomes is important. First, evaluating the
impact of anxiety symptom reduction on youth functional impairment may advance
theoretical understanding about the processes by which interventions produce positive
changes in youths’ functional status. This understanding is important given scarcity of
empirical knowledge about issues of mechanisms and theories of change in child
psychotherapy (Jensen, et al., 1999; Kazdin, 2001, 2007). Second, knowledge of how
change in youth functional impairment is achieved is important for practical reasons
because it can help to identify mediating variables that trigger this critical change. Once
15

this specific variable is identified, it can be included as the key components in the
therapeutic processes to enhance the design and delivery of existing treatment strategies
so that they will render maximally efficient (i.e., effective) interventions (Kazdin, 2001).
Third, revealing the key components that produce meaningful changes in youth
functional impairment can help to move the field beyond the current research of
treatment outcome toward research of innovative treatment models that will not only
reduce youth’s symptoms (such as anxiety) but also evoke practical and palpable
improvements in lives of youths and their families (La Greca, Silverman, & Lochman,
2009). Fourth, advancing knowledge about the mechanisms underlying the change in
youth functioning holds public health significance. That is, using empirical knowledge
about what leads to improvements in youth functional impairment, and what does not will
help to develop more efficient and effective psychosocial treatments to reduce youth
psychopathology (Berman, Weems, Silverman, & Kurtines, 2000; Kazdin, 2008).
Directionality of Change
Also important but has not been explored is the directionality of change in the
relation between anxiety symptom reduction and improvement in youth functional
impairment. Bidirectional causal relations and processes frequently appear in the
psychological theory (e.g., developmental systems theory approach; Gottlieb, 2007).
Nonetheless, empirical investigation of bidirectional influence between variables is not
frequently pursued in psychological research, which may in part be due to statistical and
methodological issues (e.g., underidentification and insolubility) inherent in the fitting of
bidirectional influence models (Bollen, 1989; Kenny, 1979). In the field of treatment
outcome, for instance, Silverman et al.’s (2009) randomized controlled trial is the only
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study to examine and find some evidence for the bidirectionality of change in the relation
between youth anxiety and parent variables (i.e., youth to parent, parent to youth, or
bidirectionally).
Extending past outcome research by evaluating empirically whether the
directionality of change to the relation between symptom reduction and youth functional
impairment is bidirectional was the fourth objective of this dissertation. This knowledge
is important given that many models currently evaluated in outcome research are based
on the assumption of unidirectional causality and thus are somewhat limited in their
theoretical and practical potential (Martner & Haase, 2006). Finding that the dynamics of
change may not only flow from symptom reduction to impairment improvement but also
from impairment improvement to symptom reduction can help to begin filling the
knowledge gap about the complex nature of the proposed mediated relation between
anxiety symptom reduction and youth functional impairment.
Moderating Roles of Youth Age, Sex, and Ethnicity
Also not examined is whether there are the moderating roles of youth age, sex,
and ethnicity with respect to the proposed mediated relation between anxiety symptom
reduction and youth functional impairment. Extending the treatment outcome research by
addressing this issue directly was the fifth objective of this dissertation. Determining
whether the proposed mediated relation between positive treatment outcomes and youth’s
functional status varies as a function of youth age is important because it can inform the
field about differences in the developmental expression of functional impairment (Weems
& Costa, 2005). Examining a moderating role of youth sex can help to expand the
conceptual understanding about protective or risk factors (Ginsburg & Silverman, 2000)
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that can strengthen or weaken, respectively, the impact of treatment gains on youth
functional impairment. Examining whether and how youth ethnicity moderates the
proposed functional impairment mediated by positive treatment outcome also may assist
in formulating and implementing psychosocial interventions sensitive to issues that may
arise in working in contexts of cultural diversity (Kurtines & Szapocznik, 1996).
Taken together, examining the moderating role of youth age, sex, and ethnicity
with respect to the effect of successful treatments on youth functional status may assist
improving the quality and clinical relevance of evidence-based treatment procedures and
outcomes because it can help clinicians to develop treatment plans that meet the needs of
a particular child. Because of the lack of past research to guide specific hypotheses with
respect to these background variables coupled with the power requirements needed for a
full and complete evaluation of these variables as potential moderators, no formal
hypotheses about these specific variables and their moderating roles were included in this
study.
Informant Agreement
No study has yet to evaluate an agreement (or lack thereof) between youths and
their parents in their view of youth functional impairment vis-à-vis anxiety reduction.
Past research suggests that in general, youths' and parents' reports on the association
between reported symptom scores and associated impairment differ, irrespective of
diagnostic type (Jensen et al., 1999; Wille, Bettge, Wittchen, & Ravens-Sieberer, 2008).
Adding to existing research by evaluating whether youths and their parents disagree in
their view of change in impairment vis-à-vis anxiety symptom reduction was the sixth
and final objective of the present study.
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Empirical knowledge about informant agreement vis-à-vis the symptomimpairment relation is important. Specifically, as discussed earlier, impairment in youth
functioning is difficult to ascertain because it is in part a subjective epiphenomenon
(Bird, 1999). Obtaining and comparing empirical information from multiple informants
(e.g., youths and their parents) can assist in better understanding how changes in youth
functional impairment vis-à-vis anxiety symptom reduction manifest. Given that anxiety,
especially generalized worry, is a psychological disturbance that is largely internally
experienced, empirically comparing youths and parents’ view of youth functional
impairment vis-à-vis anxiety reduction may also assist in establishing accurate diagnoses,
necessary for maximizing treatment gains. Moreover, using reports from multiple
informants about their view of youth functional status vis-à-vis anxiety reduction can
help to gain comprehensive information about the magnitude of impairment in youths’
functioning, which is crucial for planning, monitoring, and evaluating evidence-based
treatments for anxiety disorders in youth (Kramer et al., 2004).
The Present Study
The specific aims of this dissertation were to evaluate the following research
questions and related hypotheses:
1. What is the relation between the low, medium, and high levels of anxiety at
posttreatment, as measured by the youth and parent rated Children's Manifest Anxiety
Scale - Revised (RCMAS and RCMAS/P; Reynolds & Richmond, 1978) and
Multidimensional Anxiety Scale for Children (MASC; March, Parker, Sullivan,
Stallings, & Connors, 1997), and youth functional impairment ratings, as measured
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by both CGAS (Shaffer et al., 1983) and the combined CSR (Silverman & Albano,
1996) at posttreatment and 12-month follow up?
Hypothesis 1: The youths reporting the low and/or medium anxiety level(s) at
posttreatment will score significantly higher on the CGAS and lower on the CSR at
posttreatment and 12-month follow up, compared to those reporting high anxiety
levels.
2. Do functional impairment ratings measured by the CGAS predict impairment above
and beyond measures of anxiety severity symptoms, indicating incremental validity
of the CGAS?
Hypothesis 2. The functional impairment measured by the CGAS ratings will account
for unique variance in the combined CSR, as well as youth reports based (i.e. ADIS-C
CSR), and parent reports based (i.e., ADIS-P CSR), above and beyond the prediction
of impaired functioning from anxiety symptoms alone at posttreatment and 12-month
follow up, revealing incremental validity of the CGAS.
3. Are reductions in youth anxiety symptoms, measured by youth and parent rated
RCMAS and MASC at posttreatment, significant mediators of change in youth
functional impairment, measured by the CGAS and CSR at posttreatment and 12month follow up?
Hypothesis 3. Anxiety symptom reduction, measured by youth and parent rated
RCMAS and MASC at posttreatment, will significant mediate change in youth
functional impairment measured by the CGAS and the combined CSR at
posttreatment and follow up.
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4. What is the directionality of change in the relation between anxiety symptom
reduction and youth functional impairment?
Hypothesis 4. The proposed mediating relation between anxiety symptom reduction
and levels of functional impairment will be bidirectional, indicating that as anxiety
symptoms decrease, youth functional impairment ratings decrease as well, and vice
versa.
5. What is the role of youth’s age, sex, and ethnicity, respectively, on the proposed
youth functional impairment mediation by anxiety symptoms reduction at
posttreatment and 12-month follow up?
Due to the lack of research with regard to the respective moderating effects of youth
age, sex, and ethnicity on the mediated relation between symptom reduction and
functional impairment, no hypotheses for this particular research question were
formulated. The proposed moderator analyses were performed for the exploratory
purposes only.
6. Is there an agreement between youths and their parents in their view of youth
functional impairment vis-à-vis anxiety reduction?
Hypothesis 5. There will be a significant difference between youths’ and parents’
ratings of youth impairment as measured by the ADIS-C and ADIS-P CSRs at
posttreatment and 12-month follow up, suggesting a lack of informant agreement in
their views of youth functional impairment vis-à-vis anxiety symptom reduction.

21

CHAPTER III.
METHODOLOGY
Participants
The present study consists of analysis of an archival data set obtained from 183
youths (ages 6 to 16 years; M = 9.72; SD = 2.21) and their mothers who presented to the
Child Anxiety and Phobia Program (CAPP) at Florida International University (FIU).
The CAPP is a research clinic specializing in youth anxiety disorders and its related
difficulties. All participants were referred to the CAPP by pediatricians, school
psychologists, or other mental health professionals due to difficulties with excessive
anxiety. The participants’ age range in this current study is comparable with the age
range of past randomized clinical trials (Barrett et al., 1998; Kendall, 1994). The data
analyzed in the present study only included subjects that completed the treatment.
Sociodemographic information of the study’s participants is provided in Table 1.
As shown, 75 % of the participants were Hispanic/Latino Americans, and 54 % were
boys. The youths’ age range of 6 to 16 years reflect the modal age range of the age of
onset of separation anxiety disorder (SAD), social phobia (SOP), specific phobia, (SP),
and generalized anxiety disorders (GAD) in the population and is reflective of the
CAPP’s referral patterns.
The study’s inclusion criteria for the youth participants were: (a) primary
diagnoses of DSM-IV-TR anxiety disorder of SAD, SOP, SP, and GAD, reviewed and
confirmed at a staff conference directed by Dr. Silverman following the administration of
the ADIS-C/P (Silverman & Albano, 1996); (b) a mean score of 4 or greater on the CSR
(Silverman & Albano, 1996; see Measures); (c) discontinuation of all other youth
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psychosocial treatment upon review with the program’s clinic staff and the service
provider; (d) discontinuation of certain psychopharmacological agents that were viewed
as confounding the study, upon review with the program’s psychiatric consultant and
under medical supervision; (e) between 6 and 16 years of age; (f) mothers must agree to
participate in their youth’s treatment; and (g) agree to be randomized into either a parent
involvement (PCBT) or a group (GCBT) treatment condition.
The study’s exclusion criteria for the youth participants were: (a) primary
diagnoses of any DSM-IV-TR anxiety disorders other than SAD, SOP, SP, and GAD; or
(b) refusal to discontinue a psychosocial treatment or psychopharmacological agents as
per study’s protocol and as per medical supervision; or (c) youth and/or their mothers’
diagnoses (e.g., primary, secondary, tertiary) of Pervasive Developmental Disorders,
Mental Retardation, Organic Mental Disorders, Schizophrenia or Other Psychotic
Disorders; and/or (d) youth and/or their mothers’ demonstration of a high likelihood of
hurting themselves or others.
Measures
Functional impairment measures. Children’s Global Assessment Scale (CGAS;
Shaffer et al., 1983). The CGAS is a clinician rated scale designed to reflect levels of
functioning in youth aged 4-16 years. As previously discussed, the scale’s scores range
from 100 (the highest level of functioning) to 1(the lowest level of functioning), with
scores of 67 or higher reflecting functioning within the normal range (Bird et al., 1987).
Past research evaluating psychometric characteristics of the CGAS has yielded an
interrater reliability coefficient of .66 (intraclass correlation), revealing the scale’s
considerable strength in providing a global measure of youth functional impairment (Bird
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et al., 1987; Shaffer et al., 1983). As in past research, CGAS ratings were derived during
case presentation meetings headed by Dr. Silverman.
Clinician Severity Rating (CSR; Silverman & Albano, 1996). The CSR is an
interviewer/clinician rated scale that was designed to assess the degree of interference
associated with the symptoms of the major DSM–IV-TR disorders, such as anxiety, mood,
and externalizing disorders, experienced by school-age youth. The CSR is a part of the
ADIS - C/P (Silverman & Albano, 1996), which in addition to producing DSM–IV-TR
diagnoses, assigns the CSRs ranging from 0 (Not At All) to 8 (Very, Very Much) for each
endorsed diagnosis. The CSR of 4 or higher is viewed as definitely interfering and
impairing, and those less than 4 are viewed as subthreshold. To derive a combined score
of the CSR, an interviewer considers both the youth and parent’s views and adjusts the
interference score to the higher of the two CSRs for each endorsed diagnosis. Research
studies with the ADIS-C/P revealed its solid psychometric properties. Inter-rater
agreement for the ADIS-C/P on the pre-treatment clinician rating scale using the
interviewer-observer paradigm has been found to be .74 (Silverman, Cerny, & Nelles,
1988); .89 for test-retest for the ADIS-C, .87 for the ADIS-P, and .88 for the composite
rating (Silverman & Eisen, 1992). The CSR scores were reviewed and confirmed at a
case presentation meetings headed by Dr. Silverman following the administration of
ADIS-C/P. The CSR scores were derived prior to obtaining the CGAS ratings.
Anxiety symptom measures. Multidimensional Anxiety Scale for Children
(MASC; March et al., 1997). The MASC is a 39-item youth self-rated scale designed to
assess youth anxiety disorders. Each scale’s item is rated via a 4-point Likert scale. The
ratings of the scale’s 39 items are summed to yield a Total score of anxiety. The MASC
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is increasingly being used in youth anxiety research as it provides for a more
comprehensive and robust assessment of childhood anxiety and its disorders. The
MASC’s test-retest reliability using a 3-week and 3-month interval is satisfactory to
excellent (intra-class correlation coefficients of .93 and .87, respectively) (Baldwin &
Dadds, 2007; March & Sullivan, 1999). The MASC’s convergent and divergent validity
is also adequate. Shared variance was highest for scales sampling symptom domains of
anxiety, intermediate for depression, and lowest for externalizing symptoms (March et
al., 1997).
Children's Manifest Anxiety Scale - Revised (RCMAS; Reynolds & Richmond,
1978). RCMAS is a 37-item youth self-rated scale designed to assess youth anxiety
symptoms. A Total Anxiety score is computed based on 28 items, which are divided into
three anxiety subscales: (1) Physiological Anxiety (i.e., somatic manifestations of
anxiety, such as sleep difficulties, nausea, and fatigue); (2) Worry/Oversensitivity (i.e.,
obsessive concerns about a variety of things of a vague and ill-defined nature, as well as
fears about being hurt or emotionally isolated); and (3) Social Concerns/Concentration
(i.e., distracting thoughts and fears of a social or interpersonal nature). Each item is rated
either Yes or No and scored 1 or 0, respectively. Because scores are derived from
affirmative responses, a high score indicates a high level of anxiety or lie on that
subscale. The RCMAS is the most widely used self-rating scale in the youth anxiety
treatment research literature (see review by Silverman & Ollendick, 2005). Pela and
Reynolds (1982) reported a 3-week test-retest reliability of .98 for the Total Anxiety
scale. Significant correlations have been found between the Total Anxiety scale, trait
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anxiety, and fear (rs = .63 to .88) (Ollendick, 1983). The alpha coefficient in the present
sample was .84.
Revised Children's Manifest Anxiety Scale, Parent Version (RCMAS/P; Reynolds
& Richmond, 1978). In RCMAS/P, the wording of RCMAS items was changed from
“I...” to “My child…” as done in past research (e.g., Kendall, 1994; Silverman et al.,
1999). Each item was rated either Yes or No and scored 1 or 0, respectively. Twenty-eight
items are summed to yield a Total Anxiety score. As in the original version of the scale,
RCMAS/P contains three anxiety subscales: Physiological Anxiety,
Worry/Oversensitivity, and Social Concerns/Concentration. The alpha coefficient in the
present sample was .78.
Procedures
Assessment interviews and questionnaires were administered after parental
informed consent/child assent was obtained. All assessment interviews and
questionnaires were generally completed in one session and conducted by doctoral level
psychology graduate students. All measures were completed at pretreatment,
posttreatment, and 12-month follow up assessment points. Families who met the study’s
inclusion criteria were invited back to the clinic and informed consent/assent was
obtained for their participation in the study.
Treatment Conditions
As done in previous research (Flannery-Schroeder & Kendall, 2000; Silverman et
al., 1999), participating youth were randomly assigned to either the PCBT or GCBT in
blocks of seven. The initiation of the random assignment process to either treatment
condition (PCBT or GCBT) was determined by the toss of a coin. In GCBT condition,
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assignment to treatment in blocks of seven was used to avoid delay in the formation of
groups. To standardize the content of each treatment session, treatment manuals for
PCBT and GCBT were used in the study. In the manuals, therapists were reminded of the
main goals, tasks, and critical issues for each session, homework assignments, treatment
schedules, etc. (to view a detailed outline of the basic core program as presented to
participants, see Marin, 2010). Therapists were advised however to take into account the
developmental needs of the youth and proceed accordingly with the treatment protocol.
Given the high proportion of Hispanic families in the sample, 8% of the
treatments were delivered in a bilingual format (English and Spanish) by the request of
the Spanish-only speaking parents participating in PCBT. There were no statistically
significant differences on any of the primary outcome variables as a result of treatment
language in PCBT. All group treatments were delivered in English. The total number of
sessions in both PCBT and GCBT was 12 to 14 sessions.
In PCBT, the youth and parents met with the therapist on a weekly basis for a
total of 60 minutes. The basic core of this specific CBT format involved not only graded
exposures to anxiety provoking situations and training youths in using cognitive and
behavioral strategies, but also promoted parents’ reinforcement/support for their child’s
successful handling of his/her avoidant behaviors and improving parenting skills and the
parent-child relationship. To target “parenting skills” and “parent-child relationships,” the
PCBT involved the following main therapeutic components: (1) training parents in
managing their children’s anxiety and avoidant behaviors, (2) having parents set
appropriate contingencies for successful child non-avoidance, (3) and helping parents to
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enhance their acceptance/warmth toward their children with improved communication
and problem-solving skills.
In GCBT, the youth met in the group with the therapist on a weekly basis for a
total of 60 minutes. The basic core of this particular program involved not only graded
child exposures, but also promoted peer reinforcement/support for youth’s successful
handling of their avoidant behaviors and improving child social skills and peer-child
relationships. To target “child social skills” and “peer-child relationships,” the GCBT
involved the following main therapeutic components: (1) training youth in being more
helpful and positive toward other children in the group in the context of fear/anxiety
reduction as well as other behaviors, (2) having youth accept the help and support of
other group members in role-plays, and (3) training youth in social skills (e.g.,
compliment giving, conversational skills). As done in previous research (Barrett, 1998;
Flannery-Schroeder & Kendall, 2001), at the start of the treatment program, the middle,
and the end, the parents of the youth who have been assigned to GCBT had three brief
group meetings (about 30 minutes) with each group therapist to be informed about the
program and the youth’s tasks and activities.
Therapists
Because the two conditions require similar therapeutic skill levels, therapists were
crossed between conditions as recommended by Kazdin (1994). Crossing therapists with
treatment condition allows for an analysis of the therapist variance (i.e., the portion of
patient treatment gains attributed to the therapists) that can be separated from the
treatment variance (i.e., the portion of patient treatment gains attributed to treatment
conditions). In this study, the therapists were eight doctoral level psychology graduate
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students who received training in the proper administration of the treatments by Dr.
Silverman. The training of therapists included the following: Therapists first familiarized
themselves with the treatment protocols. Particular emphasis was placed on highlighting
both the overlap between the conditions (e.g., youth exposure) and the important
distinctions between the two conditions (e.g., parenting behaviors versus social skill
behaviors). Dr. Silverman provided both didactic and clinical training via extensive
role-playing of the treatment’s procedures. There were no statistically significant
differences between any of the therapists on any of the primary outcome variables.
During the course of the dissertation, Dr. Silverman conducted weekly
supervision meetings with the therapists to prepare for upcoming sessions and process
sessions that were just completed. This included the review of the therapists' treatment
notes, listening to a random selection of therapists' session tapes, and providing ongoing
feedback via instructions, recommendations, and role-plays.
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CHAPTER IV.
RESULTS
Preliminary and Supplemental Analyses
Outlier. Analyses were pursued using both non-model based and model-based
methods. With respect to the former, multivariate outliers were identified by calculating
leverage indices for each respondent. A leverage score four times greater than the mean
leverage was defined as an outlier. There were no outliers found in the data using this
approach. A model-based outlier analysis was also conducted. This involved regressing a
randomly selected indicator for each endogenous variable onto an indicator for variables
of which the endogenous variable was assumed to be a linear function. The regression
analysis uses ordinary least squares (OLS) regression in a limited information estimation
framework. Standardized df beta estimates were then examined for the predictors and
intercepts for each case. Outliers were defined as the absolute value of standardized df
beta scores in the excess of 1.0. No outliers were evident in the data using this approach.
Non-Normality. Univariate indices of skewness and kurtosis were examined to
determine whether the absolute value of any of these indices is greater than 2.0. Nonnormality was evident in several variables in this study. The decision was thus to pursue
structural equation modeling (SEM) analyses in Mplus 6 (Muthén & Muthén, 2007) by
using an estimator (MLR) robust to violations of normality based on the Huber-White
algorithm (Huber, 1967; White, 1980).
Missing data. In the analysis of missing data, it was first determined whether
there was a systematic bias in the patterning of missing data. This involved computing a
dummy variable reflecting the presence or absence of missing data for a given measure in
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the data. This dummy variable was then correlated with all other variables in the model as
well as an array of demographic variables. No significant correlations were observed,
indicating that there was no evidence of bias resulting from missing data.
Two types of analyses relevant to the missing data were pursed. For the analyses
using the Statistical Package for the Social Sciences (SPSS), missing data were
accommodated by using the multiple imputation strategy (Little & Rubin, 1989). For the
analyses using the SEM framework in Mplus 6, the full information maximum likelihood
(FIML) missing data methodology (Wothke, 2000) was employed.
Statistical power and sample size considerations. Structural equation modeling
requires taking into account statistical power, issues of the stability of the covariance
matrix, and the use of asymptotic theory. With regard to statistical power, however, it is
difficult to evaluate the power associated with specific path coefficients in complex SEM
models because of the large number of assumptions about population parameters that
must be made. With regard to the asymptotic theory and covariance stability, simulation
studies tend to suggest that sample sizes of 100 to 125 or larger often yield adequate
results given that reasonably reliable measures are used (reliabilities greater than 0.65)
and with a reasonable number of indicators per latent variable (Jackson, 2003; Jaccard &
Wan, 1996). The sample size of 183 participants along with psychometrically sound
measures used in the present study exceeds this standard.
Structural equation modeling. To explore the proposed models in this study, the
data were analyzed using SEM in Mplus 6. SEM is a powerful and flexible tool that,
besides assessing the directional and non-directional relationships among observed and
unobserved variables, recognizes the imperfect nature of the measurement and thus
31

explicitly specifies error terms for all the measurements in a model (Byrne, 2001). Such
specifications are important because traditional multivariate methods like regression
assume variables in the analysis are perfectly reliable or free of measurement error.
Additionally, SEM provides flexibility, more so than alternative approaches (e.g.,
regression analysis), because it does not require that a variable be either a cause or an
effect of another variable. As a result, SEM allows to test for the presence (or lack
thereof) a bidirectional causality among variables of interest. Finally, SEM affords formal
significance testing of competing conceptual models to identify those models that are the
most appropriate given the data (Byrne, 2001).
Fit indices. Model fit was evaluated with the comparative fit index (CFI) of
values ≥ 0.95, the root-mean-square error of approximation (RMSEA) of values ≤ 0.08,
and the p value for close fit test of values ≥ 0.05 representing acceptable fit (Bentler,
1990; Brown & Cudeck, 1993). More focused fit indices were also examined with
modification indices of values ≤ 3.83 and standardized residual values of ≤ 1.96
representing acceptable fit.
Covariates. In all model tests using SEM in Mplus 6, youth sex, age, and
ethnicity were used as covariates. Paths were included from each of these variables to the
mediators and outcome variables. The scores of the pretreatment measures of the CGAS
and CSR were used as covariates as well (Rausch, Maxwell, & Kelly, 2003). Correlations
were also estimated between primary and secondary outcome measures (i.e., CGAS and
CSR) at the posttreatment and follow up in both youth and parent models. To avoid
clutter, Figures 1 through 9 exclude the pretreatment scores of the outcome variables,
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youth sex, age, and ethnicity, as well as the correlations among all exogenous and
outcome variables; however, all were included in all model tests.
Clustering effects. The GCBT condition consisted of 19 separate treatment
groups of youths in blocks of seven. As a result, the model was adjusted for potential
clustering effects (19 clusters). Because each case in PCBT is independent from each
other, youth participants in the PCBT condition were also coded as separate clusters (100
clusters), for a total of 119 clusters. Given that traditional OLS regression approaches
assume independence of observations, intra-class correlation (ICC) coefficients were
calculated to examine the degree of non-independence of observations as a result of the
clustering of participants in GCBT. This calculation is important because as the ICC
increases, the amount of independent information from the data decreases, inflating the
Type I error rate of an analysis that ignores this correlation (Blair, Higgins, Topping, &
Mortimer, 1983). If clustering is not of concern, then ICC’s should be zero or near zero.
Calculation of ICC’s revealed coefficients greater than .05, which was judged to be large
enough to adjust for clustering effects. To account for clustering attributable to GCBT in
all analyses in this study, the decision was to pursue the algorithms in Mplus 6.
Tables 2 presents means and standard deviations for youth functional impairment
and anxiety symptom measures for youth and parent completed measures. As shown in
Table 2, multiple measures of anxiety (e.g., RCMAS, RCMAS/P) and functional
impairment (e.g., CGAS) obtained from multiple sources (e.g., youth, parent, and
clinicians, respectively) were used in this study. Using SPSS, a series of supplementary
analyses were conducted to examine the intercorrelations among all the measures within
each category (e.g., the category of outcome measure). The correlation between the
33

parents’ ratings of youth anxiety and the youths’ self-ratings of anxiety as measured by
respective versions of RCMAS was .15 (p = .038) at the pretest and .29 (p < .001) at the
immediate posttest. The correlation between the youths’ self-ratings of anxiety as
measured by RCMAS and MASC was .52 at the pretest and .62 at posttest, with both
being statistically significant (p < .001). The correlation between the youths’ self-ratings
of anxiety as measured by MASC and the parents’ ratings of youth anxiety as measured
by RCMAS/P was .10 at pretest and .18 at posttest, with only the latter being statistically
significant (p = .018). Given these low correlations, youth and parent ratings of anxiety
on the respective versions of the RCMAS and MASC at pre and posttreatment
assessments were treated as separate measures of youth anxiety symptoms in all model
tests.
Likewise, the correlation between the clinicians and the youths’ and parents’
ratings of functional impairment as measured by the CGAS and the CSR combined,
respectively, was -.59 at posttest and -.47 at follow up, with both being statistically
significant (p < .001). Given these moderate correlations, the CGAS and the combined
CSR ratings were treated as separate indicators of youth functional impairment.
In addition, a series of analyses were conducted to evaluate whether the scores on
RCMAS subscales (i.e., physiological anxiety, worry/oversensitivity, and social
concerns/concentration) differentially contribute to youth functional impairment ratings.
Youth and parent models pertaining to each subscale were tested separately using the
SEM framework in Mplus 6. Global and focused fit indices indicated good data fit for all
models. Path estimates were examined, and informal comparisons of path estimates of the
models were conducted. No theoretically meaningful differences in path estimates among
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the models were identified in the between - subscale comparisons. The findings did not
support the presence of differential effects of physiological symptoms of anxiety,
worry/oversensitivity, and social concerns/concentration subscale ratings on youth
functional impairment as measured by the CGAS and the CSR at posttreatment. As such,
the total scores of youth anxiety ratings measured by the youth and parent respective
versions of the RCMAS were used in all models tested in this study.
All model tests in this study were pursued using the SEM framework in Mplus 6,
unless stated otherwise.
Main Analyses
Levels of Anxiety Symptoms
The first objective in this study was to test the linkages between different levels of
anxiety (i.e., low, medium, and high) and youth functional impairment ratings at
posttreatment and follow up. Three dummy variables were created to indicate three
groups of youths who reported low, medium, and high levels of anxiety at posttreatment.
The high level of anxiety was defined as one standard deviation above the sample mean
on anxiety symptoms; the low level of anxiety was defined as one standard deviation
below the sample mean on anxiety symptoms; and the medium level of anxiety was
defined as the scores between low and high levels of anxiety. Each estimated model in
these analyses was just-identified and thus no fit indices are reported.
Youth ratings. Table 3 presents unstandardized paths coefficients and their
associated statistics, representing mean differences between the groups for youth
completed measures (i.e., RCMAS, MASC). As a reminder, high scores on the CGAS
mean ‘less impaired.’ As shown in Table 3, at posttreatment, using the RCMAS, youths
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who reported either low or medium on anxiety levels scored significantly higher on the
CGAS (β = 9.67, p <.001; or 7.24, p = .001, respectively) and lower on the CSR (β = 2.17, p <.001; or -1.87, p = .002, respectively), compared to youths who reported high
anxiety levels. Similar results were found using MASC. Youths who reported low or
medium anxiety levels scored significantly higher on the CGAS (β = 8.16, p = .002, or
8.72, p < .001, respectively) and lower on the CSR (β = - 1.56, p = .017), compared to
youths who reported high anxiety levels. In all cases, the direction of the mean difference
was toward decreased impairment vis-à-vis decreased anxiety symptom severity (see
Table 3). The significant difference effects were maintained when the Holm modified
Bonferroni method (Jaccard, 1998) was applied to control the experiment-wise error rate
at 0.05.
The evaluation of mean differences between low, medium, and high anxiety
groups for youth completed measures (i.e., RMCAS and MASC) at posttest with respect
to the CGAS and CSR scores at follow up was pursued next. No statistically significant
results were revealed in these analyses.
Parent ratings. Table 4 presents unstandardized paths coefficients and their
associated statistics, representing mean difference between the groups for parent
completed measures (i.e., RCMAS/P). As shown in Table 4, youths whose parent rated
either low or medium on anxiety levels scored significantly higher on the CGAS (β =
16.95 or 9.10, p <.001, respectively) than youths whose parent rated high on anxiety
levels. Additionally, youths whose parents rated low on anxiety levels scored
significantly higher on the CGAS (β = 7.86, p <.001), compared to youths whose parents
rated medium on anxiety levels. The significant difference effects were maintained when
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the Holm modified Bonferroni method (Jaccard, 1998) was applied to control the
experiment-wise error rate at 0.05.
Statistically significant results were also found with the CGAS ratings at follow
up, revealing that compared to youths whose parents rated high on anxiety levels, the beta
coefficient for youths whose parents rated low on anxiety levels was 8.66 (p = .026).
However, the significance of this difference effect was not maintained when the Holm
modified Bonferroni method (Jaccard, 1998) was applied to control the experiment-wise
error rate at 0.05.
With respect to the posttreatment CSR, youths whose parents rated low or
medium on anxiety levels scored significantly lower (β = -1.97, p = .001; or -1.52, p =
.007, respectively), compared to youths whose parents rated high on anxiety levels.
Similar results were found at follow up, revealing that compared to youths whose parents
rated medium or high on anxiety levels, youths whose parents rated low on anxiety levels
scored significantly lower on CSR (β = -0.89, p =.001, or -1.12, p = .008, respectively).
The significant difference effects were maintained when the Holm modified Bonferroni
method (Jaccard, 1998) was applied to control the experiment-wise error rate at 0.05.
In all cases, using parents’ ratings of youth anxiety, the direction of the mean
difference was toward decreased impairment vis-à-vis decreased anxiety symptom
severity (see Table 4).
Incremental Validity of the CGAS
The second objective of this study was to evaluate incremental validity of the
CGAS related to the CSR at the posttreatment and 12-month follow up. Using SPSS, a
two-step linear regression was pursued by entering anxiety symptom severity ratings as
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measured by the youth and parent rated RCMAS first, followed by entering the global
impairment rating measured by the CGAS as a predictor of the CSR scores. In addition to
RCMAS, MASC was also used as a measure of anxiety symptom severity. The criterion
for an adequate incremental validity of the CGAS was a statistically significant difference
between the values of adjusted R2 for the first and second steps of the model (Cohen,
1992).1
Combined CSR. Table 5 presents relevant adjusted R2s and their associated
statistics for the combined CSR (i.e., based on youth’s and parent’s views of
impairment). As shown in Table 5, at posttreatment, using the RCMAS, the results
revealed the adjusted R2 for the first step of the model to equal 0.17 and the addition of
the posttreatment CGAS ratings with the second step resulted in an adjusted R2 of 0.40.
The R2 change equaled 0.23, and this was significant (p < .001). Similar results were
found using the MASC (i.e., the R2 change = 0.35, p < .001). Using the RCMAS/P, the
results revealed the adjusted R2 for the first step of the model to equal 0.14 and the
addition of the posttreatment CGAS ratings with the second step resulted in an adjusted
R2 of 0.38. The R2 change equaled 0.23, and this was significant (p < .001).
At the follow up, using the RCMAS, the adjusted R2 for the first step of the model
was equal to 0.06 and the addition of the posttreatment CGAS ratings with the second
step resulted in an adjusted R2 of 0.25. The R2 change equaled 0.19, and this was
significant (p < .001). Similar results were found using the MASC (i.e., R2 change = 0.21,
p < .001). Using the RCMAS/P, the adjusted R2 for the first step of the model to equal
0.09 and the addition of the CGAS ratings with the second step resulted in an adjusted R2
of 0.25. The R2 change equaled 0.16, and this was significant (p < .001).
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Overall, these results suggest incremental validity of the CGAS related to the
combined CSR scores at posttreatment and follow up.
ADIS-C CSR. Table 6 presents relevant adjusted R2s and their associated
statistics for ADIS-C CSR (i.e., based on youth’s view of impairment). As shown in
Table 6, at posttreatment, using the RCMAS, the results revealed the adjusted R2 for the
first step of the model to equal 0.15 and the addition of the posttreatment CGAS ratings
with the second step resulted in an adjusted R2 of 0.20. The R2 change equaled 0.06, and
this was significant (p = .001). At follow up, results revealed the adjusted R2 for the first
step of the model to equal 0.08 and the addition of the posttreatment CGAS ratings with
the second step resulted in an adjusted R2 of 0.13. The R2 change equaled 0.05, and this
was also significant (p = .024). Similar results were found using the MASC (i.e., the R2
change equaled 0.06, p = .001; and 0.09, p = .003, at the posttreatment and the follow up,
respectively). These results suggest incremental validity of the CGAS related to the
ADIS-C CSR scores at both posttreatment and follow up.
ADIS-P CSR. Table 7 presents relevant adjusted R2s and their associated
statistics for ADIS-P CSR (based on parent’s view of impairment). As shown in Table 7,
at posttreatment, using the RCMAS/P, the results revealed that the adjusted R2 for the
first step of the model to equal 0.15 and the addition of the posttreatment CGAS ratings
with the second step resulted in an adjusted R2 of 0.39. The R2 change equaled 0.24, and
this was significant (p < .001). At follow up, results revealed that the adjusted R2 for the
first step of the model to equal 0.09 and the addition of the posttreatment CGAS ratings
with the second step resulted in an adjusted R2 of 0.17. The R2 change equaled 0.09, and
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this was also significant (p = .009). Overall, these findings suggest incremental validity
of the CGAS related to the ADIS-P CSR scores at both posttreatment and follow up.
Functional Impairment Mediation
The third objective of this dissertation was to test the proposed functional
impairment mediation by anxiety symptom reductions. The conceptual model of the
proposed mediation is depicted in Figures 1. A predictor variable of pretreatment anxiety
symptoms (e.g., Pretreatment Anxiety in Figure 1) was assumed to impact the outcome
variables of youth functional impairment as measured by the CGAS and the CSR at
posttreatment (e.g., Figure 1, path j and k) and at follow up (e.g., Figure 1, path l and m),
respectively. Paths a reflects impact of the focal independent variable (e.g., Pretreatment
Anxiety in Figure 1) on the mediator (e.g., Posttreatment Anxiety in Figure 1). Paths a
and n indicates a traditional autoregressive effect representing change in anxiety
symptoms from pre to posttreatment and posttreatment to follow up, respectively, as an
effect of intervention collapsed across PCBT and GCBT treatment conditions. Paths o
and p (also in Figure 1) also reflect traditional autoregressive effect representing change
in functional impairment measured by the CGAS and CSR, respectively, from post to
follow up as an effect of intervention collapsed across PCBT and GCBT treatment
conditions.
Paths b and c (also in Figure 1) reflect the extent to which changes in the
respective mediator (e.g., Posttreatment Anxiety) are associated with changes in the
primary and secondary outcome variables at posttreatment (e.g., Impairment as measured
by Posttreatment CGAS and Impairment as measured by Posttreatment CSR in Figure 1)
from pre to posttreatment. Paths h and i reflect the extent to which changes in anxiety
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symptoms (e.g., Follow Up Anxiety) are associated with changes in measures of
impairment from posttreatment to follow up (e.g., Impairment as measured by Follow Up
CGAS and Impairment as measured by Follow Up CSR in Figure 1). Each path
represents contemporaneous reciprocal causality (Silverman et al., 2009), in that (a)
changes in youth anxiety are assumed to impact changes in youth functional impairment,
and (b) changes in youth functional impairment are assumed to impact changes in youth
anxiety simultaneously.
Paths d and e reflect lagged effects, estimating the extent to which changes in the
youth anxiety from pretreatment to posttreatment (e.g., Posttreatment Anxiety in Figure
1) are associated with changes in youth functional impairment from posttreatment to
follow up (e.g., Impairment as measured by Follow Up GCAS and Impairment as
measured by Follow Up CSR in Figure 1, respectively). Paths f and g also reflect lagged
effects, estimating the extent to which changes in youth functional impairment variable
from pretreatment to posttreatment (e.g., Impairment as measured by Posttreatment
CGAS in Figure 1) are associated with changes in youth anxiety from posttreatment to
follow up (e.g., Follow Up Anxiety in Figure 1, path f).
With respect to mediation effects using the youth and parent models, the joint
significance test was used to examine these effects as recommended by MacKinnon,
Lockwood, Hoffman, West, and Sheets (2002). As such, the key paths of interest are a
through e. Paths a, b, and c need to be statistically significant to conclude that
posttreatment anxiety mediates, to some extent, youth functional impairment as measured
by the CGAS and CSR at posttreatment, and paths a, d, and e – at follow up.
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Youth ratings. Figure 2 represents the mediation model which was tested using
the youth’s self-ratings of anxiety (i.e., RCMAS). The model yielded a good fit to the
data. The overall chi square test of model fit was not statistically significant (χ2 (6) =
5.04, p > .05). The CFI was 1.00, the RMSEA was < .001, and the p value for the test of
close fit was 0.77. More focused tests of fit revealed no theoretically meaningful or
sizeable modification indices. The standardized residuals indicate the proportion of
unexplained variance in the endogenous variables. The variables in the model were able
to account for 24% of the variance in the RCMAS at post, 22% of the variance in the
CGAS at post, 21% of the variance in the CSR at post, 37% of the variance in the CGAS
at follow up, and 10% of the variance in the CSR at follow up.
With respect to youth functional impairment mediation using the CGAS as
outcome, path a and path b were both statistically significant (path a = 0.43, p < .001,
95% CI [0.30, 0.55]; path b = -0.57, p = <.001, 95% CI [-0.83, -0.32]), suggesting that
the hypothesized mediator of post RCMAS significantly mediated post CGAS. Given
these findings, the total indirect effect of treatment on improvement in functional status
was -0.25 (p < .001), and the total effect of treatment on impairment was -0.36 (p =
.004).2 Similar results were found using the MASC (i.e., path a = 0.45, p < .001, 95% CI
[0.33, 0.56]; path b = -0.20, p < .001, 95% CI [-0.31, -0.09]; the total indirect effect = 0.09, p = .002).
With respect to youth functional impairment mediation using the CSR as
outcome, path a and path c were both statistically significant (path c = 0.16, p < .001,
95% CI [0.10, 0.23]), suggesting that the hypothesized mediator of post RCMAS
significantly mediated post CSR. Given these findings, the total indirect effect of
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treatment on functional impairment was 0.07 (p < .001), and the total effect of treatment
on impairment as measured by the CSR at post was not statistically significant. Similar
results were found using the MASC (i.e., path c = 0.03, p = .015, 95% CI [0.006, 0.06];
the total indirect effect = 0.13, p = .01). That is, both PCBST and GCBT resulted in youth
having significant improvements in anxiety symptoms, which in turn mediated significant
improvements in youth functional status as measured by both the CGAS and CSR at
posttreatment, as reported by youths.
With respect to youth functional impairment mediation using youth self-rating of
anxiety and the CGAS and CSR at follow up as outcome, only path a was statistically
significant. As such, there is no evidence that either RCMAS or MASC at post mediates
youth functional impairment as measured by the CGAS and CSR at the follow up.
Parent ratings. Figure 3 represents the model which was tested using the parent’s
ratings of youth anxiety (i.e., RCMAS/P). The model yielded a good fit to the data. The
overall chi square test of model fit was not statistically significant (χ2 (6) = 6.41, p > .05).
The CFI was 1.00, the RMSEA was 0.019, and the p value for the test of close fit was
0.64. More focused tests of fit revealed no theoretically meaningful or sizeable
modification indices. The standardized residuals indicate the proportion of unexplained
variance in the endogenous variables. The variables in the model were able to account for
32% of the variance in RCMAS/P at post, 34% of the variance in the CGAS at post, 19%
of the variance in the CSR at post, 54% of the variance in the CGAS at follow up, and
11% of the variance in the CSR at follow up.
With respect to youth functional impairment mediation using the CGAS as
outcome, it was found that path a and path b were both statistically significant (path a =
43

0.54, p < .001, 95% CI [0.41, 0.67]; path b = -1.16, p < .001, 95% CI [-1.45, -0.86]),
suggesting that the hypothesized mediator of post RCMAS/P significantly mediated post
CGAS. Given these findings, the total indirect effect of treatment on functional status
was -0.62 (p < .001); the total effect of treatment on impairment was -0.44 (p = .012).
With respect to youth functional impairment mediation using the CSR as
outcome, it was found that both path a and path c were statistically significant (path c =
0.19, p < .001, 95% CI [0.12, 0.26]), suggesting that the hypothesized mediator of post
RCMAS significantly mediated post CSR. Given these findings, the total indirect effect
of treatment on functional impairment was 0.10 (p < .001), and the total effect of
treatment on impairment as measured by the CSR at was not statistically significant.
With respect to youth functional impairment mediation using parent measures of
youth anxiety and the CGAS and CSR at follow up as outcome, only path a was
statistically significant. As such, there is no evidence that the RCMAS/P at posttest
mediates youth functional impairment as measured by the CGAS and CSR at follow up.
Directionality of Change
The next objective of this study was to evaluate the directionality of change in the
relation between anxiety symptom reduction and youth functional impairment (i.e.,
symptom-to-impairment, impairment-to-symptom, or bidirectional). Figures 4 and 5
represent the youth and parent models, respectively, which were tested. The key paths of
interest are b through g.
As noted earlier, paths b and c represent contemporaneous change and estimate
the extent to which (a) changes in youth anxiety are assumed to impact changes in youth
functional impairment; and (b) changes in youth functional impairment are assumed to
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impact changes in youth anxiety during the same time period (i.e., from pretreatment to
posttreatment). The evaluation these reciprocal paths could not be pursued
simultaneously due to the issue of underidentification (Bollen, 1989; Kenny, 1979). As
such, it was necessary to run the youth and parent models twice: once where paths b and
c flowed from youth anxiety to the youth functional impairment variables; and a second
time where the paths flowed from youth functional impairment to youth anxiety.
The causal flow of paths b and c between the variables of anxiety and impairment
in youth and parent models was demonstrated by the previously reported findings. When
the causal direction was reversed, the paths b and c were also statistically significant,
whether using the RCMAS, (path b = -0.14, p < .001, 95% CI [-0.20, -0.08]; path c =
0.86, p < .001, 95% CI [0.46, 1.26]), the MASC (path b = -0.33, p = .001, 95% CI [-0.54,
-0.13]; path c = 1.34, p < .001, 95% CI [0.22 , 2.46]), or the RCMAS/P (path c = -0.18, p
< .001, 95% CI [-0.24, -0.13]; path c = 0.70, p < .001, 95% CI [0.42, 0.98]). Which
direction the causality should flow however is ambiguous because in both cases the same
research question is being tested: Do changes in youth anxiety produce changes in youth
functional impairment contemporaneously? As such, the significant causal flow of these
paths one way and the other does not provide an answer with respect to the directionality
of change between variables of youth anxiety and impairment in these models. According
to Jaccard & Jacoby (2010), in the analyses of bidirectional causal relationships, the
evaluation of lagged effects between the variables of interest is important given that time
interval is necessary to explain how much one variable influences the other, and vice
versa.
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As discussed earlier, paths d through g (in Figure 4) reflect lagged effects,
estimating the extent to which (a) changes in the youth anxiety from pretreatment to
posttreatment (e.g., Post RCMAS in Figure 4) are associated with changes in youth
functional impairment measured from posttreatment to follow up (e.g., Follow Up GCAS
in Figure 4, path d); and (b) the extent to which changes in youth functional impairment
variable from pretreatment to posttreatmet (e.g., Post CGAS in Figure 4) are associated
with changes in youth anxiety from posttreatment to follow up (e.g., Follow Up RCMAS
in Figure 4, path f). As such, paths d through g need to be statistically significant to
declare the bidirectionality in the symptom-to-impairment causal relation.
The results revealed that across all model tests and informants, paths d though g
were not statistically significant (see Figures 4 and 5). Similar to Silverman et al. (2009),
it was assumed that the conclusions vis-à-vis the lagged effects are the same, regardless
of the way the model is represented in terms of paths b and c. Thus, the study did not
provide empirical evidence for a reverse causal mechanism in the relation between
anxiety symptom reduction and change in youth functional impairment measured by
either the CGAS or the CSR.
Given that the paths d through g in both youth and parent models were not
statistically significant, the measures of both youth anxiety and youth functional
impairment at the follow up were not included in all following model tests.
Moderator Analyses
The fourth objective of this study, to evaluate the respective moderating effects of
youth’s age, sex, and ethnicity on the mediated relation between youth anxiety symptom
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reduction and functional impairment, was pursued using a product term approach3 and a
series of multiple group analyses.4
Youth age. Given that youth age is a continuous variable, its moderating effect on
the youth functional impairment mediation by treatment gains was evaluated using the
product term approach (Jaccard & Wan, 1996; Jaccard, Turrisi & Wan, 1990). Figure 6
and 7 represents the youth and parent models, respectively, which were tested. Of
specific interest are paths d and e, representing differential effects of youth age (e.g., Post
RCMAS*Age in Figure 6) on the slope for the regression of the primary and secondary
outcome variables (e.g., Post CGAS at and Post CSR in Figure 6) onto the mediator (e.g.,
Post RCMAS in Figure 6). As such, paths d and e need to be statistically significant to
declare an interaction effect of youth age on the mediated relation between anxiety
symptom reduction and youth functional impairment at posttreatment.
Figure 6 represents the model which was tested with youth completed measures of
anxiety (i.e., RCMAS). The model yielded a good fit to the data. The overall chi square
test of model fit was not statistically significant (χ2 (3) = 2.62, p > .05). The CFI was
1.00, the RMSEA was <.001, and the p value for the test of close fit was 0.63. More
focused tests of fit revealed no theoretically meaningful or sizeable modification indices.
Paths d and e were not statistically significant (p >.05). Similar results were found using
the MASC, suggesting a lack of significant interaction effects of youth age on the
mediated relation between anxiety symptom reduction and youth functional impairment
at posttreatment, using youth self-ratings of anxiety (i.e., RCMAS, MASC).
Figure 7 represents the model which was tested with parent ratings of youth
anxiety (i.e., RCMAS/P). This model also yielded a good fit to the data. The overall chi
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square test of model fit was not statistically significant (χ2 (3) = 5.41, p > .05). The CFI
was 0.99, the RMSEA was 0.066, and the p value for the test of close fit was 0.30. More
focused tests of fit revealed no theoretically meaningful or sizeable modification indices.
Paths d and e were not statistically significant (p >.05), suggesting a lack of significant
interaction effect of youth age on the mediated relation between anxiety symptom
reduction and youth functional impairment at posttreatment using parent rating of youth
anxiety (i.e., RCMAS/P).
In addition to the product term analyses, a series of multiple groups was pursued
based on middle childhood, late childhood, and adolescence. No evidence for moderation
was found using either youth or parent ratings of youth anxiety (i.e., RCMAS, MASC, or
RCMAS/P).
Youth sex. To assess a moderating effect of youth sex on the youth functional
impairment mediation by treatment gains, a series of multiple group analyses was
pursued. Two dummy variables were constructed to indicate boys (n = 98) and girls (n =
85) in the study’s sample. Using youth ratings of anxiety (i.e., RCMAS and MASC), a
multiple group model with regression paths constrained to be equal across youth sex
provided a good fit. The chi square test of model fit was not statistically significant (χ2
(21) = 22.41, p > .05). The CFI was .99, the RMSEA was 0.03, and the p value for the
test of close fit was 0.64. Relaxing the path equality constraint did not significantly
improved the model fit, χ2 difference (13, N = 183) = 12.59, p >.05. Similar results were
found using the MASC (i.e., χ2 difference [13, N = 183] = 11.47, p >.05).
Using parent ratings of youth anxiety (i.e., RCMAS/P), a multiple group model
with regression paths constrained to be equal across age groups provided an acceptable
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fit. The chi square test of model fit was not statistically significant (χ2 (21) = 30.60, p >
.05), the CFI was .96, the RMSEA was 0.07, and the p value for the test of close fit was
0.25. Relaxing the path equality constraint did not lead to a significantly better model fit,
χ2 difference (13, N = 183) = 17.02, p >.05. As such, using multiple group analyses
approach, the results of both the youth and parent models suggest a lack of significant
interaction effects of youth sex on the mediated relation between anxiety symptom
reduction and youth functional impairment at posttreatment across all informants.
Youth ethnicity. A moderating effect of youth ethnicity on the youth functional
impairment mediation by treatment gains was tested using multiple group analysis
method. Given the high proportion of Hispanic families in the sample (75%), only two
dummy variables were constructed to indicate youth ethnicity: Hispanics (n = 139) and
non-Hispanics (n = 44). Using youth ratings of anxiety (i.e., RCMAS and MASC), a
multiple group model with regression paths constrained to be equal across youth ethnicity
groups provided an acceptable fit. The chi square test of model fit was not statistically
significant (χ2 (21) = 32.05, p > .05). The CFI was .94, the RMSEA was 0.08, and the p
value for the test of close fit was 0.20. Relaxing the path equality constraint did not lead
to a significantly better model fit, χ2 difference (13, N = 183) = 17.82, p >.05. Similar
results were found using the MASC (i.e., χ2 difference [13, N = 183] = 15.72, p >.05.
Using parent ratings of youth anxiety (i.e., RCMAS/P), a multiple group model
with regression paths constrained to be equal across age groups provided a good fit. The
chi square test of model fit was not statistically significant (χ2 (21) = 22.10, p > .05), the
CFI was 1.00, the RMSEA was 0.02, and the p value for the test of close fit was 0.65.
Relaxing the path equality constraint did not lead to a significantly better model fit, χ2
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difference (13, N = 183) = 13.44, p >.05. As such, using multiple group analyses
approach, the results of both the youth and parent models suggest a lack of significant
interaction effects of youth ethnicity on the mediated relation between anxiety symptom
reduction and youth functional impairment at posttreatment across all informants.
Informant Agreement
The sixth and final objective of this study was to evaluate an agreement (or lack
thereof) between youths and parents’ views of youth functional impairment measured by
ADIS/C CSR and ADIS/P CSR, respectively, vis-à-vis youth anxiety reduction as
measured by the youth (i.e., RCMAS, MASC) and their parents (i.e., RCMAS/P). Figures
8 and 9 represent the youth and parent models, respectively, which were tested. The joint
significance test as recommended by MacKinnon, Lockwood, Hoffman, West, and Sheets
(2002) was used to examine mediation effects in the youth and parent models. As such,
the key paths of interest are paths a and b. That is, paths a and b need to be statistically
significant to conclude that the RCMAS at posttreatment mediates, to some extent, youth
functional impairment as measured by either the post ADIS/C CSR (in Figure 8) or the
post ADIS/P CSR (in Figure 9).
Two separate models with the CSR based on youth and parent views of
impairment at posttreatment (e.g., Post ADIS/C CSR in Figure 8 and Post ADIS-P CSR
in Figure 9, respectively) as outcome were tested separately. Both models were justidentified and as such no fit indices are reported.
Youth ratings. Using youth’s self-ratings of anxiety (i.e., RCMAS in Figure 8)
and impairment (i.e., ADIS/C CSR also in Figure 8), the model test revealed that the
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variables in the model were able to account for 24% of the variance in the RCMAS at
post and 22% of the variance in the ADIS/C CSR at post.
With respect to youth functional impairment mediation using the ADIS/P CSR as
outcome, path a and b were both statistically significant (path a = 0.44, p < .001, 95% CI
[0.32, 0.56]; path b = 0.12, p = .001, 95% CI [0.05, 0.20]), suggesting that the
hypothesized mediator of the RCMAS at post significantly mediated the ADIS/C CSR at
post. Given these findings, the total indirect effect of treatment on functional impairment
was 0.06 (p = .002), and the total effect of treatment on impairment as measured by the
ADIS/C CSR at posttreatment was not statistically significant. Similar results were found
using the MASC (i.e., path a = 0.44, p < .001, 95% CI [0.33, 0.55]; path b = 0.03, p =
.004, 95% CI [0.01, 0.05]; the total indirect effect = 0.01, p = .005).
Parent ratings. Using parent ratings of youth anxiety (i.e., the RCMAS/P in
Figure 9) and impairment (i.e., ADIS/P CSR also in Figure 9), the model test revealed
that the variables in the model were able to account for 31% of the variance in the
RCMAS at post and 24% of the variance in the ADIS/P CSR at post.
With respect to youth functional impairment mediation using the ADIS/P CSR as
outcome, path a and b were both statistically significant (path a = 0.56, p < .001, 95% CI
[0.44, 0.68]; path b = 0.21, p < .001, 95% CI [0.13, 0.28]), suggesting that the
hypothesized mediator of RCMAS at post significantly mediated the ADIS-P CSR at
post. Given these findings, the total indirect effect of treatment on functional impairment
was 0.12 (p < .001), and the total effect of treatment on impairment as measured by the
ADIS/P CSR at post was not statistically significant.
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To evaluate whether youth and parents agree in their views of change in youth
functional impairment vis-à-vis anxiety symptom reduction, path estimates were
examined, and informal comparisons of path estimates of the models were made. No
theoretically meaningful differences in path estimates between the youth and parent
models were identified in the between-source comparisons, suggesting a relative
informant agreement with respect to change in youth functional status vis-à-vis anxiety
reduction at posttreatment.
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CHAPTER V.
DISCUSSION
The present study aimed to evaluate: (1) the relation between low, medium, and
high levels of anxiety symptom severity and youth functional impairment ratings as
measured by both the C-GAS (Shaffer et al., 1983) and the CSR (Silverman & Albano,
1996); (2) whether functional impairment ratings measured by the CGAS predict
impairment above and beyond measures of anxiety severity symptoms, indicating
incremental validity of the CGAS; (3) whether the impact of psychosocial treatments
aimed at reducing youth phobic and anxiety disorders in a PCBT (targeting parenting
behaviors and the parent-youth relationship) and a GCBT (targeting youth social skills
behaviors and the peer-youth relationship) approach mediate change significantly in
youth functional status; (4) whether the proposed mediated relation between treatment
outcome (i.e., anxiety symptom reduction) and youth functional impairment vary as a
function of youth age, sex, and ethnicity; (5) the directionality of change between anxiety
symptom reduction and youth functional impairment; and (6) an agreement (or lack
thereof) between youths and their parents in their views of youth impairment vis-à-vis
anxiety symptom reduction.
Summary of Dissertation Findings
With respect to the linkages between different levels of anxiety and functional
impairment, the findings revealed that at posttreatment, youths who scored either low or
medium on anxiety reported significant reductions in functional impairment, compared to
youth who scored high on anxiety. The pattern of findings was consistent across all
posttreatment measures of youth anxiety (i.e., pre and post RCMAS, MASC, and
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RCAMS/P) and impairment outcome (i.e., post CGAS and CSR). In contrast to
expectation, these effects were maintained at follow up only when using parent ratings of
youth anxiety (i.e., pre and post RCMAS/P) and the combined CSR as outcome (i.e.,
based on both youth’s and parent’ views of impairment).
The findings also revealed that CGAS ratings predicted impairment in youth
functioning above and beyond measures of anxiety severity symptoms, demonstrating
incremental validity of the CGAS. As expected, the effects were consistent across all
assessment points (i.e., posttreatment and follow up), measures of anxiety (i.e., RCMAS,
MASC, RCMAS/P), and impairment outcome (i.e., CGAS, combined CSR, ADIS-C
CSR [i.e., based on youth’s view of impairment], and ADIS-P CSR [i.e., based on
parent’s view of impairment]).
With respect to youth functional mediation by treatment gains, results revealed
that psychosocial treatments in both PCBT and GCBT produced significant
improvements in anxiety symptoms, which in turn reduced significantly youth functional
impairment at posttest, across all measures of youth anxiety and impairment. In contrast
to expectations, these effects were not maintained at follow up.
With respect to the directionality of change between anxiety symptom reduction
and improvement in youth functional impairment, no evidence for a reverse causal path
was revealed. In contrast to expectations, the lagged effects that linked changes in anxiety
symptoms and functional impairment over time were not significant. These findings
suggest that the direction of change between the variables is symptom-to-impairment
rather than vice versa.
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No evidence was observed for the respective moderating effects of youths’ age,
sex, or ethnicity analyses on the relation between anxiety symptom reductions and
improvement of youth functioning. Results indicated that the strength or direction of the
posttreatment youth functional status mediation by treatment gains did not vary as a
function of these specific youth background characteristics.
With respect to informant agreement, no evidence for discrepancies in youths’
and parents’ views of change in youth functional impairment vis-à-vis anxiety reduction
was observed. In contrast to expectations, informal comparisons of youth and parent
model path estimates, coupled with the uniform results of mediation and moderation
model tests across both informants, did not reveal theoretically meaningful differences.
As such, the results indicated a relative agreement between youths and parents in their
perception of youth functional status mediated by treatment gains.
Contribution of the Present Study and Implications
The present study is important on theoretical, empirical, and clinical levels. Its
main contributions and potential implications on each of these levels are elaborated upon
in more detail in the following sections.
Theoretical implications. By evaluating the relation between different levels of
youth anxiety and youth impairment, the current study extends the theoretical literature
regarding the issue of arbitrary metrics inherent in testing of clinical significance of
psychosocial treatment outcome (Jaccard & Blanton, 2009; Kazdin, 1999). Findings at
what level of severity (e.g., low, medium, or high) youth anxiety test scores are linked to
meaningful real-life events – namely, observable and important change in youths’
functional status across major domains of functioning – help to reduce metric
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arbitrariness. This is because such findings convey a theoretical understanding of how
change in anxiety translates into the change in the youth’s real world experiences. That is,
the findings not only demonstrate statistically significant mean changes on a measure of
interest (e.g., anxiety), but also show that those changes have meaningful consequences
for youth in terms of their ability to effectively care for one's self, interact with others,
and meet demands of social role performance and role satisfaction in various settings and
situations. Although not sufficient to generate nonarbitrary metrics, the study’s findings
have a potential to ascertain clinical significance of treatment outcome. As noted by
Kazdin (1999), evaluation of whether change in symptoms (such as anxiety) has practical
and real world implications should be one of the criteria “along which clinical
significance ought to be evaluated” (p. 334).
Findings with respect to both the CGAS’ utility to predict youth functional
impairment independently from anxiety symptom severity measures and the lack of a
reverse causal mechanism between variables of symptoms and impairment add to
theoretical literature concerning the conceptualization of functional impairment. They
suggest that although symptoms (such as anxiety) are closely linked with and have often
been used as a proxy for impairment, these two concepts are not interchangeable and thus
should be evaluated independently (Bird, 1999; Kazdin, 1999). Empirical evidence for
incremental validity of the CGAS also advances theoretical knowledge. It suggests
that for treatment gain ascertainment, it is insufficient to detect youths who no longer
meet symptomatic criteria for one or more psychological disorders. Instead, it is just as
important to evaluate improvement in impairment associated with, but assessed
independently from, symptom reductions (Bird et al., 1993).
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Moreover, the current study extends past outcome research theoretically by
evaluating the mediated relation between variables measuring youth anxiety and
functional impairment. Such evaluations allow for verification of fit between theoretical
research and clinical application of treatment (Kazdin, 2001). Furthermore, revealing
how change in impairment is produced can help to advance theoretical knowledge about
the nature of change produced in psychosocial interventions and the specific variable
(i.e., the mediator) that trigger this critical change. Once this specific variable is
identified, it can be included as the key component in the therapeutic processes to
enhance the design and delivery of existing treatment strategies. As such, elucidating the
mediator of positive change in youth functional status can potentially inform theory
construction in youth anxiety treatment to render maximally effective interventions. That
is, empirical knowledge about what leads to meaningful changes in youth functional
impairment, and what does not can help move the field toward research of innovative
treatment models that will not only reduce youth’s symptoms but also evoke practical and
palpable improvements in lives of youths and their families (Kazdin, 1999).
It is interesting that significant mediation of functional impairment by treatment
gains were not maintained at follow up. One explanation for this finding is that both
anxiety and impairment in functioning are unstable psychological constructs that can be
influenced by a number of individual (e.g., competence, personal characteristics, and
communication styles) and contextual (e.g., the culture of the environment and society’s
goals and expectations) factors interacting in multiple and complex ways (APA, 2000).
Thus, despite the change in the respective means of anxiety symptoms from pre to
posttreatment and functional impairment ratings from posttreatment to follow up (see
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Table 2), the strength of the relation between anxiety symptoms reduction and change in
functional impairment is likely to decrease over time (Jeremy Pettit, personal
communication, September 30, 2011). Another possibility is that given a 12-month
interval between assessment points, the mediating relation between symptom reduction
and change in functional impairment may become contaminated by moderating variables
that the present study did not account for. Future studies replicating the present results
should address this and other related issues.
Empirical implications. The present study’s findings have important
contributions and potential implications on the empirical level. They add to past research
by demonstrating the utility of the CGAS in discriminating between clinical and
nonclinical groups. They also extend past research by revealing incremental validity of
the CGAS, which suggests that the CGAS predicts youth functional impairment, above
and beyond measures of anxiety symptoms.
The present study contributes to past research empirically by providing further
support for the efficacy of psychosocial treatments to reduce the severity of youth anxiety
and associated with it functional impairment (Silverman et al., 2008). Given the field’s
relative inattention to change in youth functional status vis-à-vis successful treatment
outcomes, the present study’s findings also extend past research. They suggest that
irrespective of youth age, sex, and ethnical background, reductions in the severity of
anxiety symptoms mediate significantly therapeutic effects on youth functional status, but
only at posttest. Future outcome research is warranted to continue filling empirical
knowledge gap with regard to the relation of change in symptom and impairment in
youth’s daily functioning.
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Given past research findings that parents and their youth often disagree on the
presence of diagnostic conditions, irrespective of diagnostic type (e.g., Jensen et al.,
1999), the findings with regard to informant agreement advances empirical literature. As
stated above, no evidence for youth and parent disagreement in their views of change in
impairment vis-à-vis symptom reductions was observed. This may be due in part to how
impairment in youth functioning is associated with anxiety disorders manifestations.
Youth anxiety disorders can lead to persistent, pervasive, and significant personal distress
and impairment in youths’ school performance, friendships, and family relations (APA,
2000). Thus, it is unlikely that youths and parents would fail to both recognize and report
positive change in youth functional impairment vis-à-vis anxiety symptom reduction.
Further research is warranted to reconcile past and current research findings’
inconsistencies.
Finally, the current study is, in part, a response to calls made in the treatment
research literature regarding the need for research on directionality of change in causal
relations among variables (Silverman et al., 2009). By evaluating empirically (and
finding no evidence of) whether time is necessary for the changes in anxiety to work their
way through and produce changes in functional impairment, the current study begins
filling the knowledge gap about the complex nature of the mediated relation between the
variables of anxiety symptoms and functional impairment. Future research employing
more advanced research designs and methods that would test bidirectional influence
dynamics among variables of interest is necessary.
Clinical implications. The study’s findings have important clinical implications.
They provide further evidence for the utility of cognitive behavioral treatment approaches
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(i.e., gradual exposures to anxiety provoking situations in conjunction with the use of
cognitive strategies) implemented in both PCBT and GCBT to reduce significantly the
severity of anxiety symptoms and associated with it functional impairment. Finding these
treatment approaches are efficacious whether they are delivered to young children or
adolescents, or youth with Hispanic/Latino or non- Hispanic/Latino cultural background
further suggests the developmental and cultural sensitivity of the psychosocial
interventions used in this study. This knowledge is important because it allows clinicians
flexibility in their decision making on what CBT treatment approach/technique to
implement to meet cost effectively the needs of each individual child presenting with
anxiety-related issues.
Given the findings with regard to the directionality of change, this study suggests
the likely utility of focusing in treatment first on symptom reduction. As the severity of
anxiety improves, impairment in functioning will show improvement as well. For
example, youths with social anxiety disorders are often so preoccupied with excessive
worries and bothersome thoughts that they are unable to engage in many “everyday”
activities involving the family, the peers, or the school. The youths’ inability to engage in
such activities may lead to additional problems in functioning, such as family conflicts,
impaired peer relationships, and school absenteeism (Silverman & Kurtines, 1996).
As suggested by the present findings, to help youths with social anxiety disorders in
treatment, it is useful to focus first on youths’ symptoms by implementing evidencebased approaches to target maladaptive behavioral, cognitive and affective processes.
Once symptoms are alleviated, improvement in functioning will follow because the
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youths will no longer avoid going on the family outings, socializing with friends, or
attending school.
Significant findings with respect to the relation between low and medium levels
of anxiety and functional impairment at posttreatment are also important on the clinical
level. They suggest that youths whose anxiety problems are at low or medium level are a
cause for concern, and those youths whose anxiety problem are at high level should be
considered in need of mental health services. This knowledge is important because it can
help clinicians to (1) better understand the phenomenology of anxiety disorders in youth,
(2) prioritize interventions, (3) refine diagnostic criteria, and (4) guide their decisions
with respect to resource allocation for youths and their families seeking psychological
services.
Limitations and Future Research Directions
The present study has several limitations that merit considerations when
interpreting the results. One limitation is that the mediator variable of anxiety symptom
reduction was only measured at two time points (i.e., pretreatment to posttreatment).
This is an issue because it disallowed an evaluation of whether changes in the mediator
(i.e., anxiety symptom reduction at posttreatment) precede change in the outcome (i.e.,
youth functional impairment). Future research should be pursued that takes into account
this important temporal issue by involving more frequent assessments of youth anxiety
symptoms and functional impairment on a session by session basis (Kraemer, Wilson,
Fairburn, & Agras, 2002).
A second limitation is that the parent participants were mothers. Youth anxiety
symptom reduction and functional impairment was thus evaluated only from participant
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mother’s point of view. This is an issue because information from both parents in
necessary to obtain a more complete picture of how change in youth functional
impairment vis-à-vis anxiety symptom reduction manifests. Future research based on
both mothers and fathers’ ratings in the assessment of their youth’s functional impairment
is warranted.
A third limitation is that intent-to-treat analyses were not pursued in this study.
This is an issue because without intent-to-treat analyses, it was not feasible to evaluate
differences between treatment completers and non-completers with respect to the
variables of interest. To fully understand the relation between symptom reduction and
change in functional impairment among youth with disorders, future research that pursues
analyses based on treatment completers and intent-to-treat is necessary.
Another limitation was the method of measurement of youth functional
impairment used in this study. The use of global measures of impairment such as the
CGAS and the CSR can only provide an overall assessment of problems in youth
functioning, suggesting the scales’ practical limitations (Fabiano et al., 2009). To better
understand the nature of the association of change between youth anxiety symptoms and
functional impairment, the use of specific information on impaired areas of youth
functioning is perhaps necessary. Future studies using instruments to assess youth’s
impairment in specific domains of functioning is warranted.
Despite these limitations, the present results are encouraging. Demonstrating
empirically that anxiety symptom reduction is a significant mediator of improvement in
youth functioning, the study supports past research on the efficacy of CBT in both a
PCBT and GCBT approach to improve not only the symptoms but also youth’s everyday
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functioning at home, at school, and society at large. Evaluating empirically the
directionality of change between symptoms and impairment, the current study sets the
stage for future research that will provide evidence-based explanations of the impact of
treatment gains on functional impairment among youth with anxiety disorders.
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Table 1
Demographic and Diagnostic Information by Treatment Condition
PCBT (n = 100)
Variable
Age (years)
Gender (male)
Target diagnosis
Separation anxiety
Social phobia
Specific phobia
Generalized anxiety
OCD
PD w/ Agoraphobia
PD w/out Agoraphobia
Selective Mutism
Ethnic background
Euro-American
Hispanic/Latino
African-American
Other/not reported
Annual income
$0-$20,999
$21,000-$40,999
$41,000-$60,999
$61,000-$80,999
$81,000-$99,999
$100,000-$149,999
>$150,000
Not reported
Marital Status
Married
Divorced
Single
Separated
Remarried

n

%

52

GCBT (n = 83)

M

SD

n

%

52

9.71

2.28
46

54

40
23
17
14
3
1
1
1

40
23
17
14
3
1
1
1

34 41.0
18 21.6
13 15.7
12 14.5
2
2.4
2
2.4
1
1.2
1
1.2

25
69
3
3

25
69
3
3

11 13.3
68 81.9
2
2.4
2
2.4

10
19
16
12
11
13
11
1

10.9
20.7
17.4
13
12
14.1
12
1.1

15
18
12
9
8
9
5
7

73
8
1
2
0

86.9
9.5
1.2
2.4
0.0

61 79.2
7
9.1
0
0.0
5
6.5
2
2.6

M

SD

9.86

2.17

19.7
23.7
15.8
11.8
10.5
11.8
6.6
8.7

Note. Mother’s Education = Highest education mother attained; Father’s Education =
Highest education father attained; PCBT = Parent-involvement cognitive behavior
treatment; GCBT = Group cognitive behavior treatment.
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Table 1 (Continued)
Demographic and Diagnostic Information by Treatment Condition
PCBT (n = 100)
Variable
Unmarried living
w/ partner
Widowed
Not reported
Mother’s Education
Grade school
Some high school
High school
GED
Some college
College
Bachelor’s
Master’s
Ph.D.
Technical Degree
Advanced Degree
Other/Not Reported
Father’s Education
Some grade school
Grade school
Some high school
High school
GED
Some college
College
Bachelor’s
Master’s
Ph.D.
Technical Degree
Advanced Degree
Other/Not Reported

n

%

0
0
1

M

GCBT (n = 83)
SD

n

%

0.0
0.0
1.1

2
0
3

2.6
0.0
3.8

0
3
7
3
13
20
27
12
3
3
3
1

0.0
3.2
7.4
3.2
13.7
21.1
28.4
12.6
3.2
3.2
3.2
1.1

0
1
9
1
19
15
13
9
2
8
1
1

0.0
1.3
11.4
1.3
24.1
19.0
16.5
11.4
2.5
10.1
1.3
1.3

1
2
3
6
2
14
19
21
10
6
4
4
1

1.1
2.2
3.2
6.5
2.2
15.1
20.4
22.6
10.8
6.5
4.3
4.3
1.1

1
1
5
7
3
8
16
15
11
3
8
1
0

1.3
1.3
6.3
8.9
3.8
10.1
20.3
19.0
13.9
3.8
10.1
1.3
0.0

M

Note. Mother’s Education = Highest education mother attained; Father’s Education =
Highest education father attained; PCBT = Parent-involvement cognitive behavior
treatment; GCBT = Group cognitive behavior treatment.
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SD

Table 2
Mean (Standard Deviations) for Outcome and Mediator Measures, N = 183
___________________________________________________________________________________________________
Pretreatment
Posttreatment
Follow Up
___________________________________________________________________________________________________
Outcome Measures
CGAS

55.34 (5.31)

76.09 (13.03)

79.23 (13.83)

CSR (Combined)

7.04 (1.01)

1.46 (2.54)

0.73 (1.82)

CSR based on ADIS-C

6.35 (1.37)

0.61 (1.80)

0.38 (1.36)

CSR based on ADIS-P

6.69 (1.12)

1.29 (2.42)

0.49 (1.51)

RCMAS

13.30 (6.63)

7.45 (6.37)

6.91 (6.54)

MASC

57.03 (21.95)

41.28 (19.48)

44.89 (42.52)

Mediator Measures

RCMAS/P
12.82 (5.64)
8.25 (5.75)
6.28 (5.30)
___________________________________________________________________________________________________
Note. CGAS = Children’s Global Assessment Scale; CSR = Clinician Severity Rating; ADIS-C = Anxiety Disorder
Interview Schedule for DSM-IV/Child Version; ADIS-P= Anxiety Disorders Interview Schedule for DSM-IV/Parent
Version; RCMAS = Revised Children’s Manifest Anxiety; RCMAS/P = Revised Children’s Manifest Anxiety/Parent
Version; MASC = Multidimensional Anxiety Scale for Children.
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Table 3
Mean Differences for Outcome and Youth Completed Measures
___________________________________________________________________________________________________
Parameter
SE
p Value
95% CI
___________________________________________________________________________________________________
CGAS at Post
Low-High for RCMAS

9.67

0.08

<.001

[5.18, 14.15]

Medium-High for RCMAS

7.24

0.09

.001

[2.81, 11.67]

Low-High for MASC

8.16

0.08

.002

[2.96, 13.35]

Medium-High for MASC

8.72

0.08

<.001

[4.54, 12.90]

Low-High for RCMAS

-2.17

0.11

<.001

[-3.35, -0.98]

Medium-High for RCMAS

-1.87

0.11

.002

[-3.04, -0.70]

CSR at Post

Low-High for MASC
-1.56
0.09
.017
[-2.84, -0.28]
___________________________________________________________________________________________________
Note. CGAS = Children’s Global Assessment Scale; CSR = Clinician Severity Rating; RCMAS = Revised Children’s
Manifest Anxiety; MASC = Multidimensional Anxiety Scale for Children; Post = Posttreatment.
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Table 4
Mean Differences for Outcome and Parent Completed Measures
___________________________________________________________________________________________________
Parameter
SE
p Value
95% CI
___________________________________________________________________________________________________
CGAS at Post
Low-High for RCMAS/P

16.95

0.07

<.001

[12.46, 21.45]

Medium-High for RCMAS/P

9.10

0.07

<.001

[5.18, 13.06]

Low-Medium for RCMAS/P

7.86

0.06

<.001

[3.88, 11.83]

Low-High for RCMAS/P

-1.97

0.09

.001

[-3.17, -0.77]

Medium-High for RCMAS/P

-1.52

0.10

.007

[-2.63, -0.42]

-0.88

0.05

.001

[-1.39, -0.37]

CSR at Post

CSR at FU
Low-Medium for RCMAS/P

Low-High for RCMAS/P
-1.12
0.08
.008
[-1.95, -0.30]
___________________________________________________________________________________________________
Note. CGAS = Children’s Global Assessment Scale; CSR = Clinician Severity Rating; RCMAS/P = Revised Children’s
Manifest Anxiety/Parent Version; Post = Posttreatment; FU = 12-month Follow Up.
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Table 5
Incremental Validity of the CGAS in relation to combined CSR
___________________________________________________________________________________________________
Adjusted R2 w/ CGAS
R2 Change
p Value
Adjusted R2
___________________________________________________________________________________________________
Combined CSR at Post
Youth RCMAS

0.17

0.40

0.23

<.001

Youth MASC

0.04

0.38

0.35

<.001

Parent RCMAS/P

0.14

0.38

0.23

<.001

Youth RCMAS

0.06

0.25

0.19

<.001

Youth MASC

0.04

0.25

0.22

<.001

Combined CSR at FU

Parent RCMAS/P
0.09
0.25
0.16
<.001
___________________________________________________________________________________________________
Note. CGAS = Children’s Global Assessment Scale; Combined CSR = Clinician Severity Rating based on youths’ and
parents’ views of impairment; RCMAS = Revised Children’s Manifest Anxiety; RCMAS/P = Revised Children’s Manifest
Anxiety/Parent Version; MASC = Multidimensional Anxiety Scale for Children; Post = Posttreatment; FU = 12-month
Follow Up.
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Table 6
Incremental Validity of the CGAS in relation to ADIS-C CSR
___________________________________________________________________________________________________
Adjusted R2 w/ CGAS
R2 Change
p Value
Adjusted R2
___________________________________________________________________________________________________
ADIS-C CSR at Post
Youth RCMAS

0.15

0.20

0.06

.001

Youth MASC

0.09

0.14

0.06

.001

0.08

0.13

0.05

.024

ADIS-C CSR at FU
Youth RCMAS

Youth MASC
0.02
0.11
0.09
.003
___________________________________________________________________________________________________
Note. CGAS = Children’s Global Assessment Scale; ADIS-C CSR = Clinician Severity Ratings of Impairment based on
the Anxiety Disorders Interview Schedule for DSM-IV/Child Version; RCMAS = Revised Children’s Manifest Anxiety;
MASC = Multidimensional Anxiety Scale for Children; Post = Posttreatment; FU = 12-month Follow Up.
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Table 7
Incremental Validity of the CGAS in relation to ADIS-P CSR
___________________________________________________________________________________________________
Adjusted R2 w/ CGAS
R2 Change
p Value
Adjusted R2
___________________________________________________________________________________________________
ADIS-P CSR at Post
Parent RCMAS/P

0.15

0.39

0.24

<.001

ADIS-P CSR at FU
Parent RCMAS/P
0.09
0.17
0.09
.009
___________________________________________________________________________________________________
Note. CGAS = Children’s Global Assessment Scale; ADIS-P CSR = Clinician Severity Ratings of Impairment based on the
Anxiety Disorders Interview Schedule for DSM-IV/Parent Version; RCMAS/P = Revised Children’s Manifest
Anxiety/Parent Version; MASC = Multidimensional Anxiety Scale for Children; w/ = with.
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Figure 1. Conceptual Mediation Model
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Figure 2. Youth Mediation Model with RCMAS

Note. RCMAS = Revised Children’s Manifest Anxiety; CGAS = Children’s Global
Assessment Scale; CSR = Clinician Severity Rating.
*** p <.001.
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Figure 3. Parent Mediation Model with RCMAS/P

Note. RCMAS/P = Revised Children’s Manifest Anxiety/Parent; CGAS = Children’s
Global Assessment Scale; CSR = Clinician Severity Rating.
*** p <.001.
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Figure 4. Youth Mediation Model with Reverse Paths

Note. RCMAS = Revised Children’s Manifest Anxiety; CGAS = Children’s Global
Assessment Scale; CSR = Clinician Severity Rating.
*** p <.001.
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Figure 5. Parent Mediation Model with Reverse Paths

Note. RCMAS/P = Revised Children’s Manifest Anxiety/Parent; CGAS = Children’s
Global Assessment Scale; CSR = Clinician Severity Rating.
*** p <.001.
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Figure 6. Youth Mediation Model with Product Term

Note. RCMAS = Revised Children’s Manifest Anxiety; CGAS = Children’s Global
Assessment Scale; CSR = Clinician Severity Rating; RCMAS*Age = Interaction term
between RCMAS and youth age.
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Figure 7. Parent Mediation Model with Product Term

Note. RCMAS/P = Revised Children’s Manifest Anxiety/Parent Version; CGAS =
Children’s Global Assessment Scale; CSR = Clinician Severity Rating; RCMAS/P*Age
= Interaction term between RCMAS/P and youth age.
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Figure 8. Youth Mediation Model with ADIS-C CSR

Note. RCMAS = Revised Children’s Manifest Anxiety; ADIS-C CSR = Clinician
Severity Rating of Impairment based on the Anxiety Disorders Interview Schedule for
DSM-IV/Child Version.
*** p <.001.
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Figure 9. Parent Mediation Model with ADIS-P CSR

Note. RCMAS/P = Revised Children’s Manifest Anxiety/Parent Version; ADIS-P CSR =
Clinician Severity Ratings of Impairment based on the Anxiety Disorders Interview
Schedule for DSM-IV/Parent Version.
*** p <.001.
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Footnotes
1

Due to a significant amount of missing data at follow up (more than 10 percent

on a given variable), the analyses using follow up ratings were pursued within Mplus 6
using the FIML methodology. Each estimated model in these analyses was just-identified
and thus no fit indices are reported. Given that Mplus output does not provide the values
of the R2 change and its significance (i.e., the p value), the R2 change values were
calculated manually, and its p value was obtained from the SPSS output with the lesser N
(due to missing data).
2

The total effect is a combination of the direct path from focal variable (e.g., Pre

RCMAS) to outcome variable (e.g., Post CGAS and CSR) and the indirect effect as a
result of the significant path from focal variable to the mediator (e.g., Post RCMAS).
3

As discussed in Jaccard, Turrisi and Wan (1990) and Jaccard and Wan (1996),

the product term approach is used when a proposed moderator is a continuous variable.
Product terms are computed by multiplying a mediator variable (e.g., Post RCMAS) by a
proposed moderating variable (e.g., youth age). The regression coefficient for the product
term indicates the number of units that the slope for the regression of the outcome
variable (e.g., Post CGAS and CSR) onto the mediator (e.g., Post RCMAS) changes,
given a one-unit increase in the moderator (e.g., youth age). When including variables as
product terms in the model, all continuous variables were mean centered by subtracting
each participant’s score from the mean of each variable. Mean centering is a good
strategy to ease an interpretation of path coefficients and to counter any collinearity
issues (Cohen & Cohen, 1983; Jaccard & Turrisi, 2003).
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3

When a proposed moderator is a categorical variable, using the multiple group

analysis approach is recommended (Baron & Kenny, 1986). That is, a model in which the
path coefficients were constrained to be equal across the groups of a given moderator
(e.g., sex [i.e., boys and girls]) is tested first, followed by the analysis of an unconstrained
model. The Satorra-Bentler method (Satorra, 2000) is pursued next to calculate the chi
square difference between the constrained and unconstrained models. Its statistical
significance was determined using a chi square critical values table, in which case an
interaction effect for a given moderator is declared.
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